- en: Chapter 1
  id: totrans-0
  prefs:
  - PREF_H1
  type: TYPE_NORMAL
  zh: 第一章
- en: Internet of Things (IoT) and Blockchain Applications in Pharmaceutical Supply
    Chain Provenance to Achieve Traceability, Transparency, and Authenticity
  id: totrans-1
  prefs:
  - PREF_H1
  type: TYPE_NORMAL
  zh: 物联网（IoT）和区块链应用于制药供应链溯源以实现可追溯性、透明度和真实性
- en: Yuan Sun
  id: totrans-2
  prefs:
  - PREF_UL
  type: TYPE_NORMAL
  zh: 袁孙
- en: Walvax Biotechnology Co., Ltd., China
  id: totrans-3
  prefs:
  - PREF_IND
  type: TYPE_NORMAL
  zh: 中国沃瓦克斯生物技术有限公司
- en: Syed Imran Ali
  id: totrans-4
  prefs:
  - PREF_UL
  type: TYPE_NORMAL
  zh: 赛义德·伊姆兰·阿里
- en: '[![Orcid Image](i/orcid.svg) https://orcid.org/0000-0002-6553-8210](https://orcid.org/0000-0002-6553-8210)'
  id: totrans-5
  prefs:
  - PREF_IND
  type: TYPE_NORMAL
  zh: '[![Orcid 图片](i/orcid.svg) https://orcid.org/0000-0002-6553-8210](https://orcid.org/0000-0002-6553-8210)'
- en: University of Huddersfield, UK
  id: totrans-6
  prefs:
  - PREF_IND
  type: TYPE_NORMAL
  zh: 英国哈德斯菲尔德大学
- en: ABSTRACT
  id: totrans-7
  prefs: []
  type: TYPE_NORMAL
  zh: 摘要
- en: A traceable, transparent, and authentic pharmaceutical supply chain (PSC) could
    provide a guarantee for drug safety, quality, and a better public health protection.
    A thorough review of the PSC and future research agenda are necessary to understand
    the IoT and blockchain applications in PSC provenance. A systematic review was
    conducted to study how IoT and blockchain could help to cope with the challenges
    faced by the current PSC. The descriptive and thematic analysis was conducted
    to reveal the research trends, chronological and geographical distribution of
    research, and themes. The main findings were focused on the challenges faced by
    the current PSC, opportunities for implementing IoT and blockchain in PSC, as
    well as the application of IoT and blockchain in pharmaceutical package and transportation
    processes. Additionally, the study summarizes the framework of IoT and blockchain
    integration in PSC.
  id: totrans-8
  prefs: []
  type: TYPE_NORMAL
  zh: 可追溯、透明和真实的制药供应链（PSC）可以为药品安全、质量和更好的公共健康保护提供保证。对 PSC 和未来研究议程的全面审查是必要的，以了解物联网和区块链在
    PSC 溯源中的应用。进行了系统性审查，以研究物联网和区块链如何帮助应对当前 PSC 面临的挑战。进行了描述性和主题分析，以揭示研究趋势、研究的时间和地理分布以及主题。主要发现集中在当前
    PSC 面临的挑战、在 PSC 中实施物联网和区块链的机会，以及在制药包装和运输过程中的物联网和区块链的应用。此外，研究总结了在 PSC 中物联网和区块链集成的框架。
- en: INTRODUCTION
  id: totrans-9
  prefs: []
  type: TYPE_NORMAL
  zh: 引言
- en: Medicine supplies are one of the building blocks of healthcare systems (WHO,
    2010). In the present health-conscious society, the satisfactory quality and regulatory
    compliance of drugs have gained enormous attention globally due to the significant
    risk of counterfeit and unqualified medicines that could pose to consumer health
    (Sylim et al., 2018). From manufacturing to consumption, there are multiple partners
    and intermediaries involved in the pharmaceutical supply chain (PSC). This brings
    about great traceability challenges in present centralized systems such as single
    point of failure, data manipulation, interoperability, security, stakeholder agreement,
    implementation cost, lack of standardization and regulations (Premkumar and C,
    2020, Uddin et at., 2021). Operating with legacy information platforms could not
    assist the collaboration amongst multiple participants of PSC (Vecchione, 2017).
    It also could not support the tracking and tracing of sources required to ensure
    quality, regulatory compliance, and drug security.
  id: totrans-10
  prefs: []
  type: TYPE_NORMAL
  zh: 药品供应是医疗系统的重要组成部分（WHO, 2010）。在当前注重健康的社会中，药品的满意质量和监管合规性在全球范围内引起了巨大关注，这是因为假冒和不合格药品对消费者健康可能造成的重大风险（Sylim
    等，2018）。从生产到消费，制药供应链（PSC）中涉及多个合作伙伴和中间商。这给现有的集中式系统带来了极大的可追溯性挑战，比如单点故障、数据操纵、互操作性、安全性、利益相关者协议、实施成本、缺乏标准化和监管（Premkumar
    和 C, 2020, Uddin 等，2021）。使用传统信息平台无法促进 PSC 的多个参与者之间的协作（Vecchione，2017）。它也无法支持追踪和跟踪所需的源，以确保质量、监管合规性和药品安全。
- en: Internet of things (IoT) and Blockchain technology have been brought to the
    forefront of global attention in different industries. The application of IoT
    in supply chain management could support real-time information update and monitoring
    (Premkumar and C, 2020). The blockchain technology could document everything related
    to the whole supply chain and allow information sharing across the distribution
    network in a secure manner (Bocek et al., 2017). Implementation of drug provenance
    across the whole PSC is essential to strengthen the governance and supervision
    of the pharma market (Sylim et al., 2018). Hence, the application of IoT and Blockchain
    in PSC would have a tremendous role in future pharmaceutical domain. The application
    of IoT and blockchain could help to achieve the target of track and trace capability,
    authenticity and transparency by improving the collaboration, as well as, information
    sharing amongst the PSC stakeholders.
  id: totrans-11
  prefs: []
  type: TYPE_NORMAL
  zh: 物联网（IoT）和区块链技术已经成为全球各行业关注的焦点。物联网在供应链管理中的应用可以支持实时信息更新和监控（Premkumar和C，2020）。区块链技术可以记录与整个供应链相关的所有内容，并以安全的方式允许信息在分销网络中共享（Bocek等，2017）。在整个药品供应链上实施药物溯源至关重要，以加强制药市场的治理和监督（Sylim等，2018）。因此，物联网和区块链技术在未来制药领域将发挥巨大作用。物联网和区块链技术的应用可以通过改善供应链参与者之间的协作以及信息共享，有助于实现追踪能力、真实性和透明度的目标。
- en: BACKGROUND
  id: totrans-12
  prefs: []
  type: TYPE_NORMAL
  zh: 背景
- en: Pharmaceutical Supply Chain
  id: totrans-13
  prefs: []
  type: TYPE_NORMAL
  zh: 制药供应链
- en: Supply chain is defined as a network of participants who cooperatively work
    together to convert basic materials into a specific finished product which is
    valued by end-customers (Settanni, Harrington and Srai, 2017). Supply chain also
    involves controlling, managing, and improving the flow of materials and information
    from suppliers to end-users (Harrison, et al., 2019, Uddin et at., 2021). Therefore,
    the PSC is a network between firms to produce, manage, distribute medicine and
    all the relevant information to the final buyer. The aim of PSC is aligning enterprises
    in enabling achievement of improving health status by pharmaceutical provision
    (Settanni, Harrington and Srai, 2017, Musamih et al., 2021). The PSC is complex,
    and its quality control process is strict (Vecchione, 2017, Ahmadi et al., 2020).
    From the aspect of involved participants, a typical PSC contains more than one
    participant. It not only includes the raw material suppliers, manufacturers, wholesalers,
    warehouse, distributors, retailers, and end-customers, but also the information
    agencies, government regulatory department such as Food and Drug Administration
    (FDA) (Sylim et al., 2018a, Uddin et at., 2021).
  id: totrans-14
  prefs: []
  type: TYPE_NORMAL
  zh: 供应链被定义为一个网络，参与者共同合作将基本材料转化为最终由最终客户所重视的特定成品（Settanni，Harrington和Srai，2017）。供应链还涉及控制、管理和改进从供应商到最终用户的物资和信息流动（Harrison等，2019年，Uddin等，2021年）。因此，药品供应链是企业之间的一个网络，用于生产、管理、分销药品和所有相关信息给最终购买者。药品供应链的目标是通过提供药品来使企业实现改善健康状况的目标（Settanni，Harrington和Srai，2017年，Musamih等，2021年）。药品供应链是复杂的，其质量控制过程严格（Vecchione，2017年，Ahmadi等，2020年）。从涉及参与者的角度来看，典型的药品供应链包含不止一个参与者。它不仅包括原材料供应商、制造商、批发商、仓库、分销商、零售商和最终客户，还包括信息机构、政府监管部门，如食品药品监督管理局（FDA）（Sylim等，2018a年，Uddin等，2021年）。
- en: The distribution network and regulations of PSC are complex. There are two distribution
    levels in PSC. Firstly, pharmaceutical manufacturers supply medicine from the
    point of production to the wholesaler, and this is also called the first level
    of drug distribution. In the second level of drug distribution, the products are
    transported from wholesalers to retailers, hospitals, or pharmacies (Jangir et
    al., 2019, Sunny et al., 2020). In some cases, manufacturers also distribute medicine
    directly to the government purchasers (Olson et al., 2018). From the aspect of
    regulation, the manufacturing of pharmaceutical must be in full compliance with
    Good Manufacturing Practice (GMP) to ensure that medicinal products are consistently
    manufactured and controlled to the quality standards appropriate to their intended
    use and as required by the product specification (WHO, 2010). The distribution
    chain of medical products must follow Good Distribution Practices (GDP) to guarantee
    the original quality of medicine (WHO, 2010). The whole PSC is supervised and
    monitored by FDA (Uddin et at., 2021). The typical physical drug distribution
    and information flow of PSC is shown in Figure 1.
  id: totrans-15
  prefs: []
  type: TYPE_NORMAL
  zh: PSC的分销网络和规定是复杂的。PSC有两个分销层级。首先，制药厂商从生产点向批发商供应药品，这也被称为药品分销的第一层。在第二层药品分销中，产品从批发商运送到零售商、医院或药店（Jangir等，2019年，Sunny等，2020年）。在某些情况下，制造商还直接向政府采购者分发药品（Olson等，2018年）。从监管的角度来看，药品的生产必须完全符合良好生产规范（GMP），以确保药品在其预期用途所需的质量标准和产品规范要求下得到一贯生产和控制（WHO，2010年）。医疗产品的分销链必须遵循良好的分销实践（GDP），以保证药品的原始质量（WHO，2010年）。整个PSC由FDA监督和监测（Uddin等，2021年）。PSC的典型物理药品分销和信息流如图1所示。
- en: '| Figure 1\. The pharmaceutical supply chain |'
  id: totrans-16
  prefs: []
  type: TYPE_TB
  zh: '| 图1\. 制药供应链 |'
- en: '| ![Figure978-1-7998-8367-8.ch001.f01](i/ch001.f01.png) |'
  id: totrans-17
  prefs: []
  type: TYPE_TB
  zh: '| ![图978-1-7998-8367-8.ch001.f01](i/ch001.f01.png) |'
- en: The Definition of the Internet of Things (IoT)
  id: totrans-18
  prefs: []
  type: TYPE_NORMAL
  zh: 物联网（IoT）的定义
- en: The Internet of things (IoT), is one of the latest IT evolvements, it’s the
    concept of connecting devices and internet to facilitate data collection, sharing,
    and transmission over a network (Ben-Daya, Hassini and Bahroun, 2019, Jha et al.,
    2019, Kari et al., 2019). Xu et al. (2014) indicated that the IoT network is composed
    of four fundamental layers as follows. The detailed architecture of IoT is as
    follows:.
  id: totrans-19
  prefs: []
  type: TYPE_NORMAL
  zh: 物联网（IoT）是最新的IT发展之一，它是连接设备和互联网的概念，以便在网络上进行数据收集、共享和传输（Ben-Daya，Hassini和Bahroun，2019年，Jha等，2019年，Kari等，2019年）。Xu等人（2014年）指出，物联网网络由以下四个基本层组成。物联网的详细架构如下：
- en: 1\. Sensing Layer
  id: totrans-20
  prefs:
  - PREF_UL
  type: TYPE_NORMAL
  zh: 1\. 感知层
- en: Existing hardware is integrated in this layer. Wireless smart systems with sensors
    or special tags such as RFID could sense the physical thing, as well as it acquires
    and exchange data amongst different devices.
  id: totrans-21
  prefs:
  - PREF_IND
  - PREF_UL
  type: TYPE_NORMAL
  zh: 存在的硬件集成在这一层。具有传感器或特殊标签（如RFID）的无线智能系统可以感知物理事物，并在不同设备之间获取和交换数据。
- en: 2\. Networking Layer
  id: totrans-22
  prefs:
  - PREF_UL
  type: TYPE_NORMAL
  zh: 2\. 网络层
- en: The function of the networking layer is to provide the essential network support
    and allow aggregation and sharing of information within the network.
  id: totrans-23
  prefs:
  - PREF_IND
  - PREF_UL
  type: TYPE_NORMAL
  zh: 网络层的功能是提供基本的网络支持，并允许在网络内进行信息聚合和共享。
- en: 3\. Service Layer
  id: totrans-24
  prefs:
  - PREF_UL
  type: TYPE_NORMAL
  zh: 3\. 服务层
- en: Services would be created and managed in this layer. It aims to provide services
    to satisfy users’ needs based on middleware technology.
  id: totrans-25
  prefs:
  - PREF_IND
  - PREF_UL
  type: TYPE_NORMAL
  zh: 在这一层中创建和管理服务。它旨在基于中间件技术提供满足用户需求的服务。
- en: 4\. Interface Layer
  id: totrans-26
  prefs:
  - PREF_UL
  type: TYPE_NORMAL
  zh: 4\. 接口层
- en: This layer enables users with different devices or applications to interact
    with the system, which allows IoT to acquire and process massive volume of value
    data. Giving the focus on the characteristics of IoT and the supply chain, IoT
    could be defined as a network that could connect physical things digitally (Ben-Daya,
    Hassini and Bahroun, 2019). The digital connection model could sense and interact
    with several partners in a supply chain to achieve information sharing, quickness,
    visibility, and tracking (Xu, He and Li, 2014; Clauson et al., 2018).
  id: totrans-27
  prefs:
  - PREF_IND
  - PREF_UL
  type: TYPE_NORMAL
  zh: 此层使具有不同设备或应用程序的用户能够与系统交互，从而使物联网能够获取和处理大量的价值数据。鉴于物联网和供应链的特点，可以将物联网定义为一种能够将物理事物数字化连接起来的网络（Ben-Daya，Hassini和Bahroun，2019年）。数字连接模型可以感知并与供应链中的几个合作伙伴进行交互，以实现信息共享、快速性、可见性和跟踪（Xu，He和Li，2014年；Clauson等，2018年）。
- en: The Definition of Blockchain Technology
  id: totrans-28
  prefs: []
  type: TYPE_NORMAL
  zh: 区块链技术的定义
- en: Blockchain technology was created to support bitcoin transactions at first but
    as it develops, it has evolved to be more than a platform for storage of financial
    transactions managed by cryptography. For instance, there are some cases related
    to blockchain technology application in the health, food and agriculture industry
    (Rejeb, Keogh and Treiblmaier, 2019). It is defined as “a decentralized database
    that could store and share data with trusted partners across a peer-to-peer computer
    network in a secure, tamper proof environment” (Radanović and Likić, 2018).
  id: totrans-29
  prefs: []
  type: TYPE_NORMAL
  zh: 区块链技术最初是为支持比特币交易而创建的，但随着其发展，它已经发展成为不仅仅是一个由加密技术管理的金融交易存储平台。 例如，在健康、食品和农业行业有一些与区块链技术应用相关的案例（Rejeb，Keogh和Treiblmaier，2019年）。
    它被定义为“一个分散的数据库，可以在安全的、防篡改的环境中通过点对点的计算机网络与受信任的合作伙伴共享数据”（Radanović和Likić，2018年）。
- en: Blockchain follows a decentralized network model and the data is shared and
    continuously synchronized across all nodes in the network (Sylim et al., 2018b).
    Blockchain consists of several blocks, with each block containing verified transactions,
    timestamp, current hash code and the hash code of the previous block (Xie et al.,
    2019). The new block is always connected with the previous block forming a chain
    of blocks arranged chronologically, so any change would occur disharmony (Pandey
    and Litoriya, 2020; De Aguiar et al., 2020).
  id: totrans-30
  prefs: []
  type: TYPE_NORMAL
  zh: 区块链遵循去中心化网络模型，数据在网络中的所有节点之间共享并持续同步（Sylim等，2018b年）。 区块链由多个区块组成，每个区块包含经过验证的交易、时间戳、当前哈希码和上一个区块的哈希码（Xie等，2019年）。
    新区块始终与上一个区块连接，形成按时间顺序排列的区块链，因此任何更改都会导致不协调（Pandey和Litoriya，2020年；De Aguiar等，2020年）。
- en: Generally, there are three types of blockchains, which are the public blockchain,
    the private blockchain and the consortium blockchain (De Aguiar et al., 2020;
    Molina, Delgado and Tarazona, 2019). The public blockchain, such as the Bitcoin
    network, is permission-less, and records are transparent to all nodes (Abbas et
    al., 2020). For the private blockchain, only the authorized participants could
    access the records, which provides a higher degree of privacy (De Aguiar et al.,
    2020). In the consortium blockchain, some records could be public while a part
    of records only could be shown to the specific private participants (Abbas et
    al., 2020).
  id: totrans-31
  prefs: []
  type: TYPE_NORMAL
  zh: 一般来说，有三种类型的区块链，即公共区块链、私有区块链和联盟区块链（De Aguiar等，2020年；Molina，Delgado和Tarazona，2019年）。
    公共区块链，如比特币网络，是无需许可的，记录对所有节点透明（Abbas等，2020年）。 对于私有区块链，只有授权参与者可以访问记录，这提供了更高程度的隐私（De
    Aguiar等，2020年）。 在联盟区块链中，一些记录可能是公开的，而部分记录只能显示给特定的私人参与者（Abbas等，2020年）。
- en: Treiblmaier (2019) pointed out that the main characteristics of blockchain are
    data immutability, transparency, decentralization, time-stamped‚ tamper proof
    and security. Immutability does not allow modifying digital data within the network,
    which could create an immutable and actual environment for all transactions across
    the network (Radanović and Likić, 2018; Wu et al., 2017). The transparency of
    Blockchains is especially critical for tracking products along the supply chain
    as it enables users to read-only access to previous information and to inspect
    the content of smart contracts (Kshetri, 2018).
  id: totrans-32
  prefs: []
  type: TYPE_NORMAL
  zh: Treiblmaier（2019年）指出，区块链的主要特征是数据不可变性、透明度、去中心化、时间戳、防篡改和安全性。 不可变性不允许在网络内修改数字数据，这可以为网络内的所有交易创造一个不可变且实际的环境（Radanović和Likić，2018年；Wu等，2017年）。
    区块链的透明度对于跟踪供应链中的产品尤为重要，因为它使用户只能读取先前的信息并检查智能合约的内容（Kshetri，2018年）。
- en: JUSTIFICATION OF RESEARCH
  id: totrans-33
  prefs: []
  type: TYPE_NORMAL
  zh: 研究的正当性
- en: The rationale behind doing this research is the provenance to achieve traceability,
    transparency and authenticity in the PSC. The current PSC are being increasingly
    complicated and heterogeneous as more internal and external stakeholders are involved.
    In this case, Information Technology (IT) has become and will continue to be an
    indispensable driving force for effective management of stakeholders across the
    supply chain (Rejeb, et al. 2019,). IT is capable of integrating internal processes,
    external vendors, as well as customers, therefore, the capability of acquiring,
    transmitting and communicating information within the supply chain network could
    be improved (Ben-Daya, Hassini and Bahroun, 2019). Hence, IoT and blockchain are
    the latest technologies. IoT could obtain real-time data to provide digital footprints
    (Ben-Daya, Hassini and Bahroun, 2019, Musamih et al., 2021), and Blockchain could
    provide better provenance with full traceability within the supply chain (Clauson
    et al., 2018). The application of IoT and blockchains could bring a paradigm shift
    in various areas of a PSC. So far, there is a lot of research related to blockchain
    or IoT application in a supply chain. For instance, an agricultural supply chain
    has achieved traceability by implementing blockchain (Kamble, Gunasekaran and
    Sharma, 2020, Sunny et al., 2020), while Walmart used blockchain to track food
    for better safety (Hyperledger, 2019). These literature reviews and case studies
    shows that IoT and blockchain application has a promising opportunity in information
    management and provenance in supply chains. But there is not much research focus
    on the IoT and blockchain application in the PSC. Therefore, this chapter would
    explore the application IoT and blockchain in PSC provenance to implement authenticity,
    traceability and transparency.
  id: totrans-34
  prefs: []
  type: TYPE_NORMAL
  zh: 进行这项研究的原因是在PSC中实现可追溯性、透明度和真实性。随着越来越多的内部和外部利益相关者的参与，当前的PSC变得越来越复杂和异构。在这种情况下，信息技术（IT）已成为并将继续是跨供应链利益相关者有效管理的不可或缺的驱动力（Rejeb等，2019年）。IT能够整合内部流程、外部供应商以及客户，因此，供应链网络内获取、传输和沟通信息的能力可以得到提高（Ben-Daya，Hassini和Bahroun，2019年）。因此，物联网和区块链是最新的技术。物联网可以获取实时数据以提供数字足迹（Ben-Daya，Hassini和Bahroun，2019年，Musamih等，2021年），而区块链可以在供应链内提供更好的来源追溯性（Clauson等，2018年）。物联网和区块链的应用可以在PSC的各个领域带来范式转变。到目前为止，已经有很多关于区块链或物联网在供应链中应用的研究。例如，农业供应链通过实施区块链实现了可追溯性（Kamble，Gunasekaran和Sharma，2020年，Sunny等，2020年），而沃尔玛使用区块链来跟踪食品以获得更好的安全性（Hyperledger，2019年）。这些文献综述和案例研究表明，物联网和区块链应用在供应链信息管理和来源追溯方面具有很大的机会。但是，在PSC中，物联网和区块链应用的研究重点并不多。因此，本章将探讨物联网和区块链在PSC来源方面的应用，以实现真实性、追溯性和透明度。
- en: AIMS AND OBJECTIVES
  id: totrans-35
  prefs: []
  type: TYPE_NORMAL
  zh: 目标和目的
- en: This chapter follows a Systematic Literature Review (SLR) to conduct the comprehensive
    search for academic and practitioner literature that is related to the topic of
    IoT and Blockchain applications in the PSC provenance to achieve traceability,
    transparency, and authenticity. The SLR methodology could enable the research
    process to be more structured, reliable, comprehensive and transparent.
  id: totrans-36
  prefs: []
  type: TYPE_NORMAL
  zh: 本章采用系统文献综述（SLR）对与物联网和区块链应用在PSC来源追溯性、透明度和真实性相关的学术和实践文献进行全面搜索。SLR方法能够使研究过程更加结构化、可靠、全面和透明。
- en: 'The three main objectives of the chapter are:'
  id: totrans-37
  prefs: []
  type: TYPE_NORMAL
  zh: 本章的三个主要目标是：
- en: '1\. Objective 1:'
  id: totrans-38
  prefs:
  - PREF_UL
  type: TYPE_NORMAL
  zh: 1\. 目标1：
- en: To identify the challenges for achieving traceability, transparency and authenticity
    in PSC from the existing research.
  id: totrans-39
  prefs:
  - PREF_IND
  - PREF_UL
  type: TYPE_NORMAL
  zh: 识别现有研究中实现PSC追溯性、透明度和真实性所面临的挑战。
- en: a. -What challenges are faced by current PSC and what actors caused those challenges?
  id: totrans-40
  prefs:
  - PREF_IND
  - PREF_IND
  - PREF_UL
  type: TYPE_NORMAL
  zh: a. -当前PSC面临的挑战是什么，是什么因素导致了这些挑战？
- en: '2\. Objective 2:'
  id: totrans-41
  prefs:
  - PREF_UL
  type: TYPE_NORMAL
  zh: 2\. 目标2：
- en: To produce a descriptive analysis of the opportunities and issues that IoT and
    blockchain application have on the aspect of information management and provenance
    in PSC.
  id: totrans-42
  prefs:
  - PREF_IND
  - PREF_UL
  type: TYPE_NORMAL
  zh: 对物联网和区块链应用在PSC信息管理和来源方面的机会和问题进行描述性分析。
- en: b. -What are the opportunities for IoT and blockchain application in PSC?
  id: totrans-43
  prefs:
  - PREF_IND
  - PREF_IND
  - PREF_UL
  type: TYPE_NORMAL
  zh: b. -在PSC中，物联网和区块链应用的机会是什么？
- en: '3\. Objective 3:'
  id: totrans-44
  prefs:
  - PREF_UL
  type: TYPE_NORMAL
  zh: 3\. 目标3：
- en: To provide valid insights into the main themes, methods, findings and models
    of IoT and blockchain applications in PSC.
  id: totrans-45
  prefs:
  - PREF_IND
  - PREF_UL
  type: TYPE_NORMAL
  zh: 提供物联网和区块链应用在PSC主题、方法、发现和模型方面的有效见解。
- en: c. -How to combine the IoT and blockchain in PSC provenance to implement traceability,
    transparency, and authenticity?
  id: totrans-46
  prefs:
  - PREF_IND
  - PREF_IND
  - PREF_UL
  type: TYPE_NORMAL
  zh: '- 如何将物联网和区块链结合到PSC溯源中以实现可追溯性、透明度和真实性？'
- en: MOTIVATION OF WORK
  id: totrans-47
  prefs: []
  type: TYPE_NORMAL
  zh: 工作动机
- en: This chapter researches the application of Blockchain and IoT technology towards
    the PSC to achieve traceability, transparency and authenticity. The scope of the
    study mainly covers two processes, which are the drug packaging and transportation
    processes (figure 2).
  id: totrans-48
  prefs: []
  type: TYPE_NORMAL
  zh: 本章研究区块链和物联网技术在PSC中的应用，以实现可追溯性、透明度和真实性。研究的范围主要涵盖两个过程，即药品包装和运输过程（图 2）。
- en: '| Figure 2\. Scope mapping of the chapter |'
  id: totrans-49
  prefs: []
  type: TYPE_TB
  zh: '| 图 2. 章节范围映射 |'
- en: '| ![Figure978-1-7998-8367-8.ch001.f02](i/ch001.f02.png) |'
  id: totrans-50
  prefs: []
  type: TYPE_TB
  zh: '| ![Figure978-1-7998-8367-8.ch001.f02](i/ch001.f02.png) |'
- en: For the packaging process, it involves packaging requirements. In the transportation
    process, it includes three aspects (Premkumar and C, 2020). The first aspect involves
    real-time monitoring of the medicine movement and its transportation environment
    (humidity and temperature). Second, it involves the collaboration of trading participants
    by sharing and verifying records transactions in a tamper proof environment. Third,
    is to ensure compliance with FDA and other regulatory track and trace guidelines.
    What is more important is decreasing the risk of introducing counterfeit medicine
    during the process.
  id: totrans-51
  prefs: []
  type: TYPE_NORMAL
  zh: 对于包装过程，涉及包装要求。在运输过程中，包括三个方面（Premkumar和C，2020）。第一个方面涉及对药品运动及其运输环境（湿度和温度）的实时监控。第二个方面涉及通过在防篡改环境中共享和验证记录交易来协作交易参与者。第三个方面是确保符合FDA和其他监管的追踪和追溯准则。更重要的是，在过程中减少引入假冒药品的风险。
- en: To answer the research question and objectives, the present review will systematically
    extract the literature from the multiple databases such as, ABI Inform, EBSCO
    and SCOPUS, which provides a great deal of academic and practitioner literature
    concerning the application of IoT and blockchain in the PSC.
  id: totrans-52
  prefs: []
  type: TYPE_NORMAL
  zh: 为了回答研究问题和目标，本文综述将系统地从多个数据库（如ABI Inform、EBSCO和SCOPUS）提取文献，这些文献提供了大量关于在PSC中应用物联网和区块链的学术和从业者文献。
- en: METHODOLOGY
  id: totrans-53
  prefs: []
  type: TYPE_NORMAL
  zh: 方法论
- en: The systematic literature review (SLR) method is adopted in this chapter to
    achieve the aforementioned objectives. The SLR is a clear, and repeatable methodology
    for locating, reviewing, evaluating and synthesizing the existing relevant studies
    on a specific topic comprehensively (Saunders, Mark N.K., et al, 2009; Okoli,
    2015).
  id: totrans-54
  prefs: []
  type: TYPE_NORMAL
  zh: 本章采用系统文献综述（SLR）方法来实现上述目标。SLR是一种清晰、可重复的方法，用于全面定位、审查、评估和综合特定主题的现有相关研究（Saunders，Mark
    N.K.，等，2009; Okoli，2015）。
- en: SLR is derived from medical sciences, and its importance has been recognized
    in other fields over the time as the process of SLR is clear, scientific, transparent,
    and replicable (Tranfield, Denyer and Smart, 2003). Tranfield, Denyer and Smart
    (2003) indicated that the SLR method could help to guarantee collected literature
    falls within a specific research scope. At the same time, this method could help
    reviewers to mitigate the biases and imbalance when evaluating and synthesizing
    the contribution and findings of the studies. As such, the SLR can be considered
    as a useful methodology that could help the reviewer to collect and review studies
    around the topic from a wide range of databases. At the same time, it could provide
    reliable evidence for interpreting the findings in this chapter sufficiently (Armitage
    and Keeble-allen, 2008).
  id: totrans-55
  prefs: []
  type: TYPE_NORMAL
  zh: SLR源自医学科学，并且随着时间的推移，在其他领域的重要性得到了认可，因为SLR的过程是清晰的、科学的、透明的和可重复的（Tranfield，Denyer和Smart，2003）。Tranfield，Denyer和Smart（2003）指出，SLR方法可以帮助确保收集的文献符合特定的研究范围。同时，该方法可以帮助审阅者在评估和综合研究的贡献和发现时减轻偏见和不平衡。因此，SLR可被视为一种有用的方法论，可帮助审阅者从广泛的数据库中收集和审查围绕该主题的研究。同时，它可以为本章的研究结果提供足够可靠的证据（Armitage和Keeble-allen，2008）。
- en: The Comparison of Systematic Literature Review and Traditional Review
  id: totrans-56
  prefs: []
  type: TYPE_NORMAL
  zh: 系统文献综述与传统综述的比较
- en: Popay et al. (2006) recommended applying SLR when reviewing literature because
    when compared to traditional review methods, the benefits of SLR are prominent.
    The detailed differences between the traditional review and SLR are listed in
    table 1.
  id: totrans-57
  prefs: []
  type: TYPE_NORMAL
  zh: Popay等人（2006）建议在进行文献综述时应用SLR，因为与传统综述方法相比，SLR的好处更加突出。传统综述和SLR之间的详细差异列在表 1 中。
- en: Table 1\. The comparison of traditional and systematic literature review
  id: totrans-58
  prefs: []
  type: TYPE_NORMAL
  zh: 表 1. 传统文献综述和系统文献综述的比较
- en: '| Differences | Good quality SLR | Traditional reviews |'
  id: totrans-59
  prefs: []
  type: TYPE_TB
  zh: '| 差异 | 良好质量的SLR | 传统综述 |'
- en: '| Review question | Begin with clear question to be answered or hypothesis
    to be tested. | May also begin with clear question to be answered, but they more
    often include general discussion of subject with no stated hypothesis. |'
  id: totrans-60
  prefs: []
  type: TYPE_TB
  zh: '| 综述问题 | 以清晰的问题开始，以回答或测试假设。 | 也可能以明确的问题开始，但更常见的是包含对主题的一般讨论，没有明确的假设陈述。 |'
- en: '| Searching for relevant studies | Attempt to collect all relevant published
    and unpublished studies to limit influence of publication and other biases. |
    Usually do not strive to collect all relevant papers. |'
  id: totrans-61
  prefs: []
  type: TYPE_TB
  zh: '| 搜索相关研究 | 试图收集所有相关的已发表和未发表的研究，以限制出版和其他偏见的影响。 | 通常不努力收集所有相关的论文。 |'
- en: '| Deciding studies to be reviewed | Involve detailed selection criteria of
    what type of papers could be selected to limit selection bias on behalf of reviewer
    | Usually do not describe the selected criteria. |'
  id: totrans-62
  prefs: []
  type: TYPE_TB
  zh: '| 决定要审查的研究 | 涉及详细的选择标准，以限制评审人员的选择偏见 | 通常不描述所选标准。 |'
- en: '| Assessing study quality | Involve quality appraisal and description evaluation
    of each study which increases the standard of reviews. | Do not consider quality
    of evidence and lack of clear methodology. |'
  id: totrans-63
  prefs: []
  type: TYPE_TB
  zh: '| 评估研究质量 | 包括每个研究的质量评价和描述评估，从而提高评论的标准。 | 不考虑证据质量和缺乏明确的方法论。 |'
- en: '| Summarize study results | The study results are most methodologically sound,
    which are based on the conclusions of studies reviewed | Usually do not differentiate
    between methodologically sound and unsound studies |'
  id: totrans-64
  prefs: []
  type: TYPE_TB
  zh: '| 总结研究结果 | 研究结果具有最具有方法论意义的，这些结果是基于所审查的研究的结论的 | 通常不区分具有方法论意义和不具有方法论意义的研究 |'
- en: 'Source: (Armitage and Keeble-allen, 2008)'
  id: totrans-65
  prefs: []
  type: TYPE_NORMAL
  zh: 来源：（Armitage和Keeble-allen，2008）
- en: Stages of Systematic Literature Review
  id: totrans-66
  prefs: []
  type: TYPE_NORMAL
  zh: 系统文献综述的阶段
- en: To achieve transparency, comprehensiveness and objectivity, the systematic literature
    review was conducted in four stages as seen in Figure 3.
  id: totrans-67
  prefs: []
  type: TYPE_NORMAL
  zh: 为了实现透明度、全面性和客观性，系统文献综述分为四个阶段，如图3所示。
- en: Scoping
  id: totrans-68
  prefs: []
  type: TYPE_NORMAL
  zh: 范围界定
- en: 'The first stage of SLR is scoping that is mapping relevant literature with
    specific research questions. The main focus of this research on provenance of
    PSC with traceability, transparency and authenticity. The technologies like Blockchain
    and IoT are used for enhancing the provenance. To achieve this following research
    questions are formulated:'
  id: totrans-69
  prefs: []
  type: TYPE_NORMAL
  zh: SLR的第一阶段是范围界定，即将相关文献与具体的研究问题进行映射。这项研究的主要焦点是PSC的溯源，重点关注溯源、透明度和真实性。区块链和物联网等技术用于增强溯源。为了实现这一目标，制定了以下研究问题：
- en: RQ.1. What are traceability issues in present PSC?
  id: totrans-70
  prefs:
  - PREF_UL
  type: TYPE_NORMAL
  zh: RQ.1. 现有PSC中的可追溯性问题是什么？
- en: RQ.2. In what ways blockchain and IoT aided in enhancing traceability of PSC?
  id: totrans-71
  prefs:
  - PREF_UL
  type: TYPE_NORMAL
  zh: RQ.2. 区块链和物联网在增强PSC的可追溯性方面有什么帮助？
- en: RQ.3. What are the challenges faced by PSC in achieving provenance?
  id: totrans-72
  prefs:
  - PREF_UL
  type: TYPE_NORMAL
  zh: RQ.3. PSC在实现溯源过程中面临的挑战是什么？
- en: RQ.4. What are the opportunities in implementing IoT and blockchain in PSC?
  id: totrans-73
  prefs:
  - PREF_UL
  type: TYPE_NORMAL
  zh: RQ.4. 在PSC中实施物联网和区块链的机会是什么？
- en: '| Figure 3\. Systematic literature review stages |'
  id: totrans-74
  prefs: []
  type: TYPE_TB
  zh: '| 图3。系统文献综述阶段 |'
- en: '| ![Figure978-1-7998-8367-8.ch001.f03](i/ch001.f03.png) |'
  id: totrans-75
  prefs: []
  type: TYPE_TB
  zh: '| ![Figure978-1-7998-8367-8.ch001.f03](i/ch001.f03.png) |'
- en: Search Strategy
  id: totrans-76
  prefs: []
  type: TYPE_NORMAL
  zh: 搜索策略
- en: Establishing a search strategy is a crucial stage for searching relevant literature.
    In this subsection, the purpose of developing a search strategy is to identify
    applicable information sources related to IoT and blockchain applications in PSC.
    Appropriate databases, search strings and keywords need to be defined in this
    stage. Notably, the search strings or keywords might need to be modified according
    to the evaluation of the search result.
  id: totrans-77
  prefs: []
  type: TYPE_NORMAL
  zh: 制定搜索策略是搜索相关文献的关键阶段。在这个子部分中，制定搜索策略的目的是识别与PSC中的物联网和区块链应用相关的适用信息来源。在这个阶段需要定义适当的数据库、搜索字符串和关键字。值得注意的是，搜索字符串或关键字可能需要根据搜索结果的评估进行修改。
- en: Database Selection
  id: totrans-78
  prefs: []
  type: TYPE_NORMAL
  zh: 数据库选择
- en: Appropriate data sources can facilitate a comprehensive SLR. Three suitable
    databases were selected for conducting the research, and they are ABI Inform,
    SCOPUS, and Business Source Complete (EBSCO). The characteristics and brief introduction
    of selected databases is described in table 2.
  id: totrans-79
  prefs: []
  type: TYPE_NORMAL
  zh: 适当的数据来源可以促进全面的SLR。为进行研究选择了三个适当的数据库，它们是ABI Inform、SCOPUS和Business Source Complete（EBSCO）。所选数据库的特点和简介如表2所述。
- en: Keywords and Search Strings
  id: totrans-80
  prefs: []
  type: TYPE_NORMAL
  zh: 关键词和搜索字符串
- en: Four groups of keywords have been designed for the main search, which are IoT,
    Blockchain and Pharmaceutical supply chain. To generate the search strings with
    high usability, these keywords were modified after the initial searching and reading
    of references. Table 3 presents the search strings.
  id: totrans-81
  prefs: []
  type: TYPE_NORMAL
  zh: 为主要搜索设计了四组关键词，分别是物联网、区块链和制药供应链。为了生成具有高可用性的搜索字符串，在初步搜索和参考文献阅读之后修改了这些关键词。表 3 展示了搜索字符串。
- en: Using the logical operator ‘AND’ to combine these individual strings. The search
    strings is (Pharmaceutical* OR drug* OR medicine OR vaccin*) AND (“supply chain*”
    OR “supply network*” OR “distribution network*” OR “demand chain*” OR “value chain*”)
    AND (Blockchain OR “internet of things” OR “web of things” OR “artificial intelligence”
    OR “big data”)
  id: totrans-82
  prefs: []
  type: TYPE_NORMAL
  zh: 使用逻辑运算符‘AND’来组合这些个别字符串。搜索字符串为（Pharmaceutical* OR drug* OR medicine OR vaccin*）AND（“供应链*”
    OR “供应网络*” OR “分销网络*” OR “需求链*” OR “价值链*”）AND（区块链 OR “物联网” OR “物联网” OR “人工智能”
    OR “大数据”）
- en: Table 2\. The characteristics of selected databases
  id: totrans-83
  prefs: []
  type: TYPE_NORMAL
  zh: 表 2\. 选定数据库的特征
- en: '| Database | Characteristics |'
  id: totrans-84
  prefs: []
  type: TYPE_TB
  zh: '| 数据库 | 特征 |'
- en: '| ABI/Inform (ProQuest) | ABI/INFORM has the gold standard in the field of
    business research databases. ABI/INFORM consists of over 40 million business-related
    documents and 90% of the documents contain full text. It includes content such
    as journals, key trade publications, business press, conference proceedings and
    market reports. |'
  id: totrans-85
  prefs: []
  type: TYPE_TB
  zh: '| ABI/Inform（ProQuest） | ABI/INFORM在商业研究数据库领域拥有金标准。ABI/INFORM包含超过4000万份与商业相关的文档，其中90%的文档包含全文。内容包括期刊、重要行业出版物、商业新闻、会议记录和市场报告。
    |'
- en: '| EBSCO (Business Source Complete) | EBSCO is the foremost provider of research
    databases, journals, magazine, e-books and discovery service to libraries of all
    kinds. It provides “over 550,000 e-books plus subscription management services
    for 360,000 e-journals, e-journal packages and print journals”. |'
  id: totrans-86
  prefs: []
  type: TYPE_TB
  zh: '| EBSCO（商业源完整版） | EBSCO是各类图书馆提供研究数据库、期刊、杂志、电子书和发现服务的主要提供商。它提供“超过55万种电子书以及为36万种电子期刊、电子期刊包和印刷期刊提供的订阅管理服务”。
    |'
- en: '| SCOPUS | Scopus offers more than 5,000 international publishers. It includes
    scientific journals, books and conference proceedings in different broad fields.
    |'
  id: totrans-87
  prefs: []
  type: TYPE_TB
  zh: '| SCOPUS | Scopus提供了超过5000家国际出版商。它包括不同广泛领域的科学期刊、书籍和会议记录。 |'
- en: Table 3\. Keywords identification
  id: totrans-88
  prefs: []
  type: TYPE_NORMAL
  zh: 表 3\. 关键词识别
- en: '| Keywords | String |'
  id: totrans-89
  prefs: []
  type: TYPE_TB
  zh: '| 关键词 | 字符串 |'
- en: '| pharmaceutical | Pharmaceutical* OR drug* OR medicine OR vaccin* |'
  id: totrans-90
  prefs: []
  type: TYPE_TB
  zh: '| 制药 | Pharmaceutical* OR drug* OR medicine OR vaccin* |'
- en: '| Supply chain | “supply chain*” OR “supply network*” OR “distribution network*”
    OR “demand chain*” OR “value chain*” |'
  id: totrans-91
  prefs: []
  type: TYPE_TB
  zh: '| 供应链 | “供应链*” 或 “供应网络*” 或 “分销网络*” 或 “需求链*” 或 “价值链*” |'
- en: '| Blockchain and IoT | Blockchain OR “internet of things” OR “web of things”
    OR “artificial intelligence” OR “big data” |'
  id: totrans-92
  prefs: []
  type: TYPE_TB
  zh: '| 区块链和物联网 | 区块链 或 “物联网” 或 “物联网” 或 “人工智能” 或 “大数据” |'
- en: Selection and Evaluation
  id: totrans-93
  prefs: []
  type: TYPE_NORMAL
  zh: 选择和评估
- en: The main operations in this stage are setting robust selection criteria, conducting
    the title, abstract screening and full-text screening to select the articles from
    the preliminary search result. Aiming to ensure the relevance and quality of the
    literature and constrain the number of final references needed to be read.
  id: totrans-94
  prefs: []
  type: TYPE_NORMAL
  zh: 该阶段的主要操作包括设定健壮的选择标准，进行标题、摘要筛选和全文筛选，以从初步搜索结果中选择文章。旨在确保文献的相关性和质量，并限制需要阅读的最终参考文献数量。
- en: Criteria for the First Screening
  id: totrans-95
  prefs: []
  type: TYPE_NORMAL
  zh: 第一轮筛选标准
- en: The first screening focus on the title and abstract. Setting the exclusion criteria
    to explain the reason of certain literature will be removed from the research.
    The detailed criteria of this step is outlined in Table 4.
  id: totrans-96
  prefs: []
  type: TYPE_NORMAL
  zh: 第一轮筛选重点放在标题和摘要上。设定排除标准以解释为什么某些文献将被从研究中移除。该步骤的详细标准概述在表 4 中。
- en: Table 4\. The exclusion criteria with reasons
  id: totrans-97
  prefs: []
  type: TYPE_NORMAL
  zh: 表 4\. 排除标准及原因
- en: '| Criteria | Exclusion | Rationale |'
  id: totrans-98
  prefs: []
  type: TYPE_TB
  zh: '| 标准 | 排除 | 原因 |'
- en: '| Relevance | Articles out of the topic of interest | To avoid unproductive
    research and resource waste caused. |'
  id: totrans-99
  prefs: []
  type: TYPE_TB
  zh: '| 相关性 | 超出感兴趣主题的文章 | 避免不必要的研究和资源浪费。 |'
- en: '| Language | Non-English articles | To avoid misunderstanding that might be
    occurred in translation. |'
  id: totrans-100
  prefs: []
  type: TYPE_TB
  zh: '| 语言 | 非英文文章 | 为避免可能发生的翻译误解。 |'
- en: '| Time coverage | Articles published before 2010 (expect for articles which
    are highly relevant and quality.) | Articles published long time ago might have
    restricted contribution to recent research due to the rapid development of technologies.
    |'
  id: totrans-101
  prefs: []
  type: TYPE_TB
  zh: '| 时间范围 | 2010年前发表的文章（除了高度相关和质量较高的文章） | 由于技术的快速发展，很久以前发表的文章可能对最新研究的贡献有所限制。 |'
- en: '| Type of publication | Any type of publication other than academic journals
    (expect for articles which are highly relevant) | To control the quality of selected
    articles as well as to ensure these articles are eligible and provide the best
    evidence to support current review. |'
  id: totrans-102
  prefs: []
  type: TYPE_TB
  zh: '| 出版类型 | 除了学术期刊之外的任何类型出版物（除了高度相关的文章） | 控制所选文章的质量，确保这些文章符合资格，并提供最佳证据支持当前的回顾。
    |'
- en: '| Peer-review | Articles which are not peer reviewed | To guarantee the quality
    and validity of articles. |'
  id: totrans-103
  prefs: []
  type: TYPE_TB
  zh: '| 同行评审 | 未经同行评审的文章 | 以保证文章的质量和有效性。 |'
- en: '| Availability | Articles which cannot be acquired as full text | Full-text
    availability would constrain effective evaluation of the literature. |'
  id: totrans-104
  prefs: []
  type: TYPE_TB
  zh: '| 可获得性 | 无法获得全文的文章 | 全文可获得性将限制对文献的有效评估。 |'
- en: Criteria for Full-Text Screening
  id: totrans-105
  prefs: []
  type: TYPE_NORMAL
  zh: 完整文本筛选标准
- en: The articles should be further evaluated for the usability, quality and relevance
    through full paper screening to select a fewer number of articles for review.
    The aim of this step is to look for points which are traceable, transparent, and
    authentic. This is to select articles that could support achieving the objectives,
    contribute to develop research as well as provide the necessary information.
  id: totrans-106
  prefs: []
  type: TYPE_NORMAL
  zh: 应该进一步评估文章的可用性、质量和相关性，通过全文筛选选择少量文章进行回顾。这一步的目的是寻找可追溯、透明和真实的要点。选择文章的目的是支持实现目标，促进研究发展，并提供必要的信息。
- en: Data Extraction and Synthesis
  id: totrans-107
  prefs: []
  type: TYPE_NORMAL
  zh: 数据提取和综合
- en: Data extraction is a process of extracting and recording useful data from the
    selected articles to prepare information for synthesis. In order to ensure the
    transparency, traceability of the review process, as well as to facilitate the
    exploration of articles, the authors have extracted all the details on data extraction
    form i.e. Table 5 (Tranfield, Denyer and Smart, 2003).
  id: totrans-108
  prefs: []
  type: TYPE_NORMAL
  zh: 数据提取是从选定的文章中提取和记录有用数据的过程，以准备信息进行综合。为了确保审查过程的透明性、可追溯性，以及便于文章的探索，作者已提取了所有关于数据提取表格的细节，即表5（Tranfield,
    Denyer and Smart, 2003）。
- en: Table 5\. The data extraction form
  id: totrans-109
  prefs: []
  type: TYPE_NORMAL
  zh: 表5. 数据提取表格
- en: '| Ref No |'
  id: totrans-110
  prefs: []
  type: TYPE_TB
  zh: '| 参考编号 |'
- en: '| Citation: |'
  id: totrans-111
  prefs: []
  type: TYPE_TB
  zh: '| 引用: |'
- en: '| Title: |'
  id: totrans-112
  prefs: []
  type: TYPE_TB
  zh: '| 标题: |'
- en: '| Author(s): |'
  id: totrans-113
  prefs: []
  type: TYPE_TB
  zh: '| 作者: |'
- en: '| Journal / Source: |'
  id: totrans-114
  prefs: []
  type: TYPE_TB
  zh: '| 期刊/来源: |'
- en: '| Year: |'
  id: totrans-115
  prefs: []
  type: TYPE_TB
  zh: '| 年份: |'
- en: '| Country of origin |'
  id: totrans-116
  prefs: []
  type: TYPE_TB
  zh: '| 来源国家 |'
- en: '| Key words: |'
  id: totrans-117
  prefs: []
  type: TYPE_TB
  zh: '| 关键词: |'
- en: '| Content of Article |'
  id: totrans-118
  prefs: []
  type: TYPE_TB
  zh: '| 文章内容 |'
- en: '| Research Question(s)/Objectives: |'
  id: totrans-119
  prefs: []
  type: TYPE_TB
  zh: '| 研究问题/目标: |'
- en: '| Study Method: |'
  id: totrans-120
  prefs: []
  type: TYPE_TB
  zh: '| 研究方法: |'
- en: '| Quality assessment |'
  id: totrans-121
  prefs: []
  type: TYPE_TB
  zh: '| 质量评估 |'
- en: '| Relevant themes |'
  id: totrans-122
  prefs: []
  type: TYPE_TB
  zh: '| 相关主题 |'
- en: '| Grounding Literature: |'
  id: totrans-123
  prefs: []
  type: TYPE_TB
  zh: '| 文献基础: |'
- en: '| Contribution |'
  id: totrans-124
  prefs: []
  type: TYPE_TB
  zh: '| 贡献 |'
- en: '| Scope covered |'
  id: totrans-125
  prefs: []
  type: TYPE_TB
  zh: '| 覆盖范围 |'
- en: '| Key Findings |'
  id: totrans-126
  prefs: []
  type: TYPE_TB
  zh: '| 关键发现 |'
- en: '| Key prepositions and arguments: |'
  id: totrans-127
  prefs: []
  type: TYPE_TB
  zh: '| 关键前提和论点: |'
- en: '| Limitations and Scope for further research: |'
  id: totrans-128
  prefs: []
  type: TYPE_TB
  zh: '| 限制和进一步研究的范围: |'
- en: '| Synthesis/ Key contribution to review question |'
  id: totrans-129
  prefs: []
  type: TYPE_TB
  zh: '| 综合/回顾问题的关键贡献 |'
- en: Reporting of the Findings
  id: totrans-130
  prefs: []
  type: TYPE_NORMAL
  zh: 结果报告
- en: The data extraction forms were used for reporting the results in descriptive
    analysis. Meanwhile, the extraction forms also helped in the logical characteristics
    of the topic and organization of various literature to develop themes and framework.
  id: totrans-131
  prefs: []
  type: TYPE_NORMAL
  zh: 数据提取表格用于报告描述性分析结果。同时，提取表格还有助于主题的逻辑特征和各种文献的组织，以制定主题和框架。
- en: DESCRIPTIVE FINDINGS
  id: totrans-132
  prefs: []
  type: TYPE_NORMAL
  zh: 描述性结果
- en: Detailed descriptive findings of the selected literature from three databases
    would be provided in this section. The data findings include the characteristics
    of the article source, the year of publication, research types and the number
    of papers per journal. The descriptive statistics would be presented both in figures
    and percentages in visible charts or tables for better explanation and review.
  id: totrans-133
  prefs: []
  type: TYPE_NORMAL
  zh: 将从三个数据库中选择的文献的详细描述性发现提供在本节中。数据发现包括文章来源的特征，出版年份，研究类型以及每期期刊的文章数量。描述性统计将以图表或表格的形式以数字和百分比呈现，以便更好地解释和审查。
- en: The SLR Execution Results
  id: totrans-134
  prefs: []
  type: TYPE_NORMAL
  zh: SLR执行结果
- en: 399 references were obtained from the three databases by adopting search strings
    mentioned in methodology section. The database named SCOPUS provided 174 articles.
    ABI/Inform provided 158 articles and EBSCO contributed 67 papers. Figure 4 shows
    the contribution of the initial research result from each database. It is clear
    that SCOPUS captured the most papers, contributing about 44% of the whole search
    followed by ABI/Inform and EBSCO accounting for around 39% and 17% separately.
  id: totrans-135
  prefs: []
  type: TYPE_NORMAL
  zh: 通过采用方法论部分提到的搜索字符串，从三个数据库中获得了399个参考文献。名为SCOPUS的数据库提供了174篇文章。ABI/Inform提供了158篇文章，EBSCO贡献了67篇论文。图4展示了来自每个数据库的初始研究结果的贡献。显然，SCOPUS捕获了最多的论文，约占整个搜索的44%，其次是ABI/Inform和EBSCO分别占约39%和17%。
- en: '| Figure 4\. The initial results from database searching |'
  id: totrans-136
  prefs: []
  type: TYPE_TB
  zh: '| 图4. 数据库搜索的初步结果 |'
- en: '| ![Figure978-1-7998-8367-8.ch001.f04](i/ch001.f04.png) |'
  id: totrans-137
  prefs: []
  type: TYPE_TB
  zh: '| ![Figure978-1-7998-8367-8.ch001.f04](i/ch001.f04.png) |'
- en: The process included screening all the relevant papers according to the selection
    criteria. It lays emphasis on quality control. The selected studies are highly
    correlated with the research topic. Articles were screened based on the publication
    year between 2010 to 2020 in the English language, and they are from full-text
    academically and scholarly (peer-reviewed) journals. At the same time, selected
    studies intend to include the papers that had been cited highly and the journals
    with high ranking in the academic field. After de-duplication and screening, the
    total number of articles for this review are 52\. The records of the outcomes
    are shown in Figure 5.
  id: totrans-138
  prefs: []
  type: TYPE_NORMAL
  zh: 过程包括根据选择标准筛选所有相关论文。它强调质量控制。所选研究与研究主题高度相关。文章基于2010年至2020年的英文出版年份进行筛选，并且是来自全文学术和学术（同行评审）期刊的。同时，所选研究旨在包括被高度引用的论文和在学术领域具有高排名的期刊。在去重和筛选之后，本综述的文章总数为52。结果的记录如图5所示。
- en: The Distribution of Selected Articles Based on Source Types
  id: totrans-139
  prefs: []
  type: TYPE_NORMAL
  zh: 基于来源类型选择的文章分布
- en: '52 articles collected from three databases could be considered as eligible
    sources for the research since the data retrieved from these electronic databases
    were dependable and effective. All of these databases offer advanced limitation
    and filtering function, as well as provide some key information of each individual
    article such as citation times to support the quality analysis. Figure 6 presents
    the statistics of the source types of the selected articles. It is clear from
    the pie chart that a majority of literature related to IoT or blockchain applications
    in PSC were from conference papers, with about 44%. For academic peer-reviewed
    journals, 37% contribute to the final selected articles. The academic journals
    were written by researchers or experts in a particular academic area. The detailed
    data of overall articles can be divided into four different source types:'
  id: totrans-140
  prefs: []
  type: TYPE_NORMAL
  zh: 从三个数据库收集的52篇文章可以视为研究的合格来源，因为从这些电子数据库检索的数据是可靠且有效的。所有这些数据库都提供了先进的限制和过滤功能，以及提供了每篇文章的一些关键信息，如引用次数以支持质量分析。图6展示了所选文章的来源类型统计数据。从饼图可以清楚地看出，与PSC中的IoT或区块链应用相关的大多数文献来自会议论文，约占44%。对于学术同行评议期刊，37%的文章对最终选定的文章做出了贡献。学术期刊是由特定学术领域的研究人员或专家撰写的。总体文章的详细数据可分为四种不同的来源类型：
- en: • 19 Academic peer-reviewed journals
  id: totrans-141
  prefs:
  - PREF_UL
  type: TYPE_NORMAL
  zh: • 19个学术同行评议期刊
- en: • 24 Conference papers
  id: totrans-142
  prefs:
  - PREF_UL
  type: TYPE_NORMAL
  zh: • 24个会议论文
- en: • 8 Trade journals
  id: totrans-143
  prefs:
  - PREF_UL
  type: TYPE_NORMAL
  zh: • 8个商业期刊
- en: • 1 Book chapter
  id: totrans-144
  prefs:
  - PREF_UL
  type: TYPE_NORMAL
  zh: • 1章节书籍
- en: '| Figure 5\. Flow diagram of literature search and selection criteria |'
  id: totrans-145
  prefs: []
  type: TYPE_TB
  zh: '| 图5. 文献搜索和选择标准的流程图 |'
- en: '| ![Figure978-1-7998-8367-8.ch001.f05](i/ch001.f05.png) |'
  id: totrans-146
  prefs: []
  type: TYPE_TB
  zh: '| ![Figure978-1-7998-8367-8.ch001.f05](i/ch001.f05.png) |'
- en: '| Figure 6\. The distribution of selected literature based on source types
    |'
  id: totrans-147
  prefs: []
  type: TYPE_TB
  zh: '| 图6. 基于来源类型选择的文献分布 |'
- en: '| ![Figure978-1-7998-8367-8.ch001.f06](i/ch001.f06.png) |'
  id: totrans-148
  prefs: []
  type: TYPE_TB
  zh: '| ![Figure978-1-7998-8367-8.ch001.f06](i/ch001.f06.png) |'
- en: Chronological Distribution
  id: totrans-149
  prefs: []
  type: TYPE_NORMAL
  zh: 时间分布
- en: Only articles published between 2010 and 2020 were included in the final review
    list that is based on the exclusion criteria. Figure 7 shows the distribution
    of selected articles’ across publication years. As per the chosen search strings,
    the time span of articles came out to be 8 years, with the earliest article dating
    back to the year 2010 and the latest contribution was from the year 2020\. The
    data presents that the highest rate of articles used in this research published
    in 2019, which is 33%, followed by 2020, 2018, and 2017 with 24%, 22%, and 9%
    respectively. From 2015 to 2019, the number of research papers increases with
    the advance of time significantly.
  id: totrans-150
  prefs: []
  type: TYPE_NORMAL
  zh: 仅包括在最终审查清单中的 2010 年至 2020 年间发表的文章，该清单基于排除标准。图 7 显示了所选文章按出版年份的分布情况。根据所选的搜索字符串，文章的时间跨度为
    8 年，最早的文章可追溯到 2010 年，最新的贡献来自 2020 年。数据显示，本研究使用的文章中，2019 年的发表率最高，为 33%，其次是 2020
    年、2018 年和 2017 年，分别为 24%、22% 和 9%。从 2015 年到 2019 年，随着时间的推移，研究论文数量显著增加。
- en: '| Figure 7\. The distribution of articles published between 2010 and 2020 |'
  id: totrans-151
  prefs: []
  type: TYPE_TB
  zh: '| 图 7\. 2010 年至 2020 年间发表的文章分布情况 |'
- en: '| ![Figure978-1-7998-8367-8.ch001.f07](i/ch001.f07.png) |'
  id: totrans-152
  prefs: []
  type: TYPE_TB
  zh: '| ![Figure978-1-7998-8367-8.ch001.f07](i/ch001.f07.png) |'
- en: Journals Contributed to the Review
  id: totrans-153
  prefs: []
  type: TYPE_NORMAL
  zh: 参与审查的期刊
- en: Table 6 depicts the reviewed articles that were from 18 different journals.
    The table includes information about the name, field and CABS ranking of academic
    journals, as well as the number of articles per journal. From figure 8, it is
    evident that 25% of articles were from the 2 and 4-star ranking journals on the
    basis of the CABS 2018 Journal Guide. However, 20% of papers were from 1-star
    ranking and 65% of articles were from non-ranked journals such as the Journal
    of Medical Internet Research.
  id: totrans-154
  prefs: []
  type: TYPE_NORMAL
  zh: 表 6 描述了审查的文章来自 18 种不同的期刊。该表包括学术期刊的名称、领域和 CABS 排名，以及每个期刊的文章数量信息。从图 8 可以看出，基于
    CABS 2018 期刊指南，有 25% 的文章来自 2 星级和 4 星级期刊。然而，20% 的论文来自 1 星级期刊，65% 的文章来自未被排名的期刊，例如《医学互联网研究杂志》。
- en: Table 6\. The list of academic journals contributed to the review
  id: totrans-155
  prefs: []
  type: TYPE_NORMAL
  zh: 表 6\. 参与审查的学术期刊列表
- en: '| No. | Academic journals | Field | Journal Ranking | Number of articles |'
  id: totrans-156
  prefs: []
  type: TYPE_TB
  zh: '| 编号 | 学术期刊 | 领域 | 期刊排名 | 文章数量 |'
- en: '| 1 | Production & Operations Management | Ops &Tech | 4 | 1 |'
  id: totrans-157
  prefs: []
  type: TYPE_TB
  zh: '| 1 | 生产与运营管理 | Ops &Tech | 4 | 1 |'
- en: '| 2 | Computers & Industrial Engineering | Ops &Tech | 2 | 1 |'
  id: totrans-158
  prefs: []
  type: TYPE_TB
  zh: '| 2 | 计算机与工业工程 | Ops &Tech | 2 | 1 |'
- en: '| 3 | International Journal of Information Management. | Info man | 2 | 1 |'
  id: totrans-159
  prefs: []
  type: TYPE_TB
  zh: '| 3 | 国际信息管理期刊 | 信息管理 | 2 | 1 |'
- en: '| 4 | Journal of the Association for Information Systems | Info man | 2 | 1
    |'
  id: totrans-160
  prefs: []
  type: TYPE_TB
  zh: '| 4 | 信息管理协会期刊 | 信息管理 | 2 | 1 |'
- en: '| 5 | International Journal of Physical Distribution & Logistics Management
    | Ops &Tech | 2 | 1 |'
  id: totrans-161
  prefs: []
  type: TYPE_TB
  zh: '| 5 | 国际物流与供应链管理期刊 | Ops &Tech | 2 | 1 |'
- en: '| 6 | Intelligent Systems in Accounting, Finance & Management | Finance | 1
    | 1 |'
  id: totrans-162
  prefs: []
  type: TYPE_TB
  zh: '| 6 | 会计、金融与管理智能系统 | 金融 | 1 | 1 |'
- en: '| 7 | International Journal of Engineering Business Management | Ops &Tech
    | 1 | 1 |'
  id: totrans-163
  prefs: []
  type: TYPE_TB
  zh: '| 7 | 国际工程商业管理期刊 | Ops &Tech | 1 | 1 |'
- en: '| 8 | ACM Computing Surveys | n/a | n/a | 1 |'
  id: totrans-164
  prefs: []
  type: TYPE_TB
  zh: '| 8 | ACM 计算调查 | n/a | n/a | 1 |'
- en: '| 9 | Applied Health Economics and Health Policy | n/a | n/a | 1 |'
  id: totrans-165
  prefs: []
  type: TYPE_TB
  zh: '| 9 | 应用健康经济学和健康政策 | n/a | n/a | 1 |'
- en: '| 10 | Electronics (Switzerland) | n/a | n/a | 2 |'
  id: totrans-166
  prefs: []
  type: TYPE_TB
  zh: '| 10 | 电子学（瑞士） | n/a | n/a | 2 |'
- en: '| 11 | Information (Switzerland) | n/a | n/a | 1 |'
  id: totrans-167
  prefs: []
  type: TYPE_TB
  zh: '| 11 | 信息期刊（瑞士） | n/a | n/a | 1 |'
- en: '| 12 | International Journal of Advanced Science and Technology | n/a | n/a
    | 1 |'
  id: totrans-168
  prefs: []
  type: TYPE_TB
  zh: '| 12 | 国际高级科学与技术期刊 | n/a | n/a | 1 |'
- en: '| 13 | International Journal of Environmental Research and Public Health |
    n/a | n/a | 1 |'
  id: totrans-169
  prefs: []
  type: TYPE_TB
  zh: '| 13 | 国际环境研究与公共健康期刊 | n/a | n/a | 1 |'
- en: '| 14 | International Journal of Scientific and Technology Research | n/a |
    n/a | 2 |'
  id: totrans-170
  prefs: []
  type: TYPE_TB
  zh: '| 14 | 国际科学与技术研究期刊 | n/a | n/a | 2 |'
- en: '| 15 | Journal of Information Security and Applications | n/a | n/a | 1 |'
  id: totrans-171
  prefs: []
  type: TYPE_TB
  zh: '| 15 | 信息安全与应用期刊 | n/a | n/a | 1 |'
- en: '| 16 | Journal of Medical Internet Research | n/a | n/a | 1 |'
  id: totrans-172
  prefs: []
  type: TYPE_TB
  zh: '| 16 | 医学互联网研究杂志 | n/a | n/a | 1 |'
- en: '| 17 | Wireless Personal Communications | n/a | n/a | 1 |'
  id: totrans-173
  prefs: []
  type: TYPE_TB
  zh: '| 17 | 无线个人通信期刊 | n/a | n/a | 1 |'
- en: '| Total |  |  |  | 19 |'
  id: totrans-174
  prefs: []
  type: TYPE_TB
  zh: '| 总计 |  |  |  | 19 |'
- en: 'Note:'
  id: totrans-175
  prefs: []
  type: TYPE_NORMAL
  zh: 注：
- en: Ops &Tech = Operations and Technology Management
  id: totrans-176
  prefs: []
  type: TYPE_NORMAL
  zh: Ops &Tech = 运营与技术管理
- en: Info man = Information Management
  id: totrans-177
  prefs: []
  type: TYPE_NORMAL
  zh: Info man = 信息管理
- en: n/a = not applicable
  id: totrans-178
  prefs: []
  type: TYPE_NORMAL
  zh: n/a = 不适用
- en: 'Source: the author (2020)'
  id: totrans-179
  prefs: []
  type: TYPE_NORMAL
  zh: 来源：作者（2020）
- en: '| Figure 8\. Percentage distribution of number of articles by journal rank
    |'
  id: totrans-180
  prefs: []
  type: TYPE_TB
  zh: '| 图 8\. 按期刊排名分布的文章百分比 |'
- en: '| ![Figure978-1-7998-8367-8.ch001.f08](i/ch001.f08.png) |'
  id: totrans-181
  prefs: []
  type: TYPE_TB
  zh: '| ![Figure978-1-7998-8367-8.ch001.f08](i/ch001.f08.png) |'
- en: Apart from the academic journals, there were 24 conference papers, 9 trade journals
    and 1 book chapter that could provide highly relevant and up-to-date information
    about the research area. The retained information covered various aspects concerning
    IoT, blockchain and other new tech and combination strategies to address the concerns
    related to transparency, traceability and authenticity of PSC. The details of
    the conference papers are shown in Table 7.
  id: totrans-182
  prefs: []
  type: TYPE_NORMAL
  zh: 除了学术期刊外，还有24篇会议论文，9篇行业期刊和1篇书籍章节可以提供与研究领域高度相关且最新的信息。保留的信息涵盖了关于物联网、区块链和其他新技术以及组合策略来解决与PSC的透明度、追溯性和真实性相关的问题的各个方面。会议论文的详细信息如表7所示。
- en: Table 7\. The list of conference papers contributed to the review
  id: totrans-183
  prefs: []
  type: TYPE_NORMAL
  zh: 表7. 为评论做出贡献的会议论文列表
- en: '| No. | Conference papers | Year | Number of articles |'
  id: totrans-184
  prefs: []
  type: TYPE_TB
  zh: '| 编号 | 会议论文 | 年份 | 文章数量 |'
- en: '| 1 | The 5th International Conference on Computer Sciences and Convergence
    Information Technology | 2010 | 1 |'
  id: totrans-185
  prefs: []
  type: TYPE_TB
  zh: '| 1 | 第五届国际计算机科学与融合信息技术会议 | 2010 | 1 |'
- en: '| 2 | The 8th International Conference on Supply Chain Management and Information
    Systems: Logistics Systems and Engineering | 2010 | 1 |'
  id: totrans-186
  prefs: []
  type: TYPE_TB
  zh: '| 2 | 第八届供应链管理和信息系统国际会议：物流系统与工程 | 2010 | 1 |'
- en: '| 3 | Communications in Computer and Information Science | 2015&2019 | 2 |'
  id: totrans-187
  prefs: []
  type: TYPE_TB
  zh: '| 3 | 计算机与信息科学通讯 | 2015&2019 | 2 |'
- en: '| 4 | IFIP/IEEE International Symposium on Integrated Network and Service Management
    | 2017 | 1 |'
  id: totrans-188
  prefs: []
  type: TYPE_TB
  zh: '| 4 | IFIP/IEEE集成网络与服务管理国际研讨会 | 2017 | 1 |'
- en: '| 5 | Advances in Transdisciplinary Engineering | 2018 | 1 |'
  id: totrans-189
  prefs: []
  type: TYPE_TB
  zh: '| 5 | 跨学科工程的进展 | 2018 | 1 |'
- en: '| 6 | IEEE 2018 International Congress on Cybermatics | 2018 | 1 |'
  id: totrans-190
  prefs: []
  type: TYPE_TB
  zh: '| 6 | IEEE 2018年国际智能技术大会 | 2018 | 1 |'
- en: '| 7 | Lecture Notes of the Institute for Computer Sciences, Social-Informatics
    and Telecommunications Engineering | 2018 | 1 |'
  id: totrans-191
  prefs: []
  type: TYPE_TB
  zh: '| 7 | 计算机科学、社会信息学和电信工程学院讲义 | 2018 | 1 |'
- en: '| 8 | The 10th International Conference on Computing, Communication and Networking
    Technologies | 2019 | 2 |'
  id: totrans-192
  prefs: []
  type: TYPE_TB
  zh: '| 8 | 第十届计算、通信和网络技术国际会议 | 2019 | 2 |'
- en: '| 9 | The 11th International Conference on Communication Systems and Networks
    | 2019 | 1 |'
  id: totrans-193
  prefs: []
  type: TYPE_TB
  zh: '| 9 | 第十一届国际通信系统与网络会议 | 2019 | 1 |'
- en: '| 10 | The 6th IEEE International Conference on Advances in Computing, Communication
    and Control | 2019 | 1 |'
  id: totrans-194
  prefs: []
  type: TYPE_TB
  zh: '| 10 | 第六届IEEE国际计算、通信和控制会议 | 2019 | 1 |'
- en: '| 11 | The 6th International Conference on Information Technology, Computer
    and Electrical Engineering | 2019 | 1 |'
  id: totrans-195
  prefs: []
  type: TYPE_TB
  zh: '| 11 | 第六届信息技术、计算机和电气工程国际会议 | 2019 | 1 |'
- en: '| 12 | ACM International Conference Proceeding Series | 2019 | 1 |'
  id: totrans-196
  prefs: []
  type: TYPE_TB
  zh: '| 12 | ACM国际会议论文集系列 | 2019 | 1 |'
- en: '| 13 | 2019 IEEE Region 10 Conference | 2019 | 1 |'
  id: totrans-197
  prefs: []
  type: TYPE_TB
  zh: '| 13 | 2019年IEEE第10地区会议 | 2019 | 1 |'
- en: '| 14 | IFIP Advances in Information and Communication Technology | 2019 | 1
    |'
  id: totrans-198
  prefs: []
  type: TYPE_TB
  zh: '| 14 | IFIP信息与通信技术进展 | 2019 | 1 |'
- en: '| 15 | International Conference on “Information Technology and Nanotechnology”
    | 2019 | 1 |'
  id: totrans-199
  prefs: []
  type: TYPE_TB
  zh: '| 15 | “信息技术和纳米技术”国际会议 | 2019 | 1 |'
- en: '| 16 | Lecture Notes in Computer Science | 2019 | 1 |'
  id: totrans-200
  prefs: []
  type: TYPE_TB
  zh: '| 16 | 计算机科学讲义 | 2019 | 1 |'
- en: '| 17 | 2019 IEEE International Conference on Intelligent Systems and Green
    Technology | 2019 | 1 |'
  id: totrans-201
  prefs: []
  type: TYPE_TB
  zh: '| 17 | 2019年IEEE国际智能系统和绿色技术会议 | 2019 | 1 |'
- en: '| 18 | Winter Simulation Conference | 2019 | 1 |'
  id: totrans-202
  prefs: []
  type: TYPE_TB
  zh: '| 18 | 冬季模拟会议 | 2019 | 1 |'
- en: '| 19 | The 9th International Conference on Cloud Computing, Data Science and
    Engineering | 2019 | 1 |'
  id: totrans-203
  prefs: []
  type: TYPE_TB
  zh: '| 19 | 第九届云计算、数据科学与工程国际会议 | 2019 | 1 |'
- en: '| 20 | The 6th International Conference on Advanced Computing and Communication
    Systems | 2020 | 1 |'
  id: totrans-204
  prefs: []
  type: TYPE_TB
  zh: '| 20 | 第六届高级计算与通信系统国际会议 | 2020 | 1 |'
- en: '| 21 | The 6th International Conference on Mobile and Secure Services | 2020
    | 1 |'
  id: totrans-205
  prefs: []
  type: TYPE_TB
  zh: '| 21 | 第六届移动与安全服务国际会议 | 2020 | 1 |'
- en: '| 22 | International Conference on Industry 4.0 and Smart Manufacturing | 2020
    | 1 |'
  id: totrans-206
  prefs: []
  type: TYPE_TB
  zh: '| 22 | 工业4.0与智能制造国际会议 | 2020 | 1 |'
- en: Geographical Distribution of Articles
  id: totrans-207
  prefs: []
  type: TYPE_NORMAL
  zh: 文章的地理分布
- en: The countries of origin could offer another way of looking into the situation
    of IoT and blockchain applications in PSC, as different locations might have different
    research levels of technology application. Figure 9 shows the geographic of the
    selected articles. It is found that authors from the USA published the most numbers
    of relevant articles, which are 29%. India takes up 26% of the total articles,
    followed by China (11%) and Italy (7%).
  id: totrans-208
  prefs: []
  type: TYPE_NORMAL
  zh: 来源国可能提供另一种了解 PSC 中物联网和区块链应用情况的方式，因为不同地区可能具有不同的技术应用研究水平。图 9 展示了选定文章的地理位置。发现来自美国的作者发表了最多数量的相关文章，占总文章的
    29%。印度占总文章的 26%，紧随其后的是中国（11%）和意大利（7%）。
- en: '| Figure 9\. Geographical distributions of articles |'
  id: totrans-209
  prefs: []
  type: TYPE_TB
  zh: '| 图 9\. 文章的地理分布 |'
- en: '| ![Figure978-1-7998-8367-8.ch001.f09](i/ch001.f09.png) |'
  id: totrans-210
  prefs: []
  type: TYPE_TB
  zh: '| ![Figure978-1-7998-8367-8.ch001.f09](i/ch001.f09.png) |'
- en: The Identification of Research Themes
  id: totrans-211
  prefs: []
  type: TYPE_NORMAL
  zh: 研究主题的识别
- en: The relevant papers collected from the SLR process revealed insightful knowledge
    and strategies for adoption of IoT and blockchain technologies in PSC. To obtain
    more findings in a specific area, the collected articles should be classified
    as different insight themes that match the scope of the study by analyzing. Table
    8 demonstrates the themes of all reviewed studies covered within the framework
    for addressing the research questions of this chapter.
  id: totrans-212
  prefs: []
  type: TYPE_NORMAL
  zh: 从 SLR 过程中收集的相关论文揭示了关于在 PSC 中采用物联网和区块链技术的深入知识和策略。为了在特定领域获得更多发现，应通过分析将收集的文章分类为符合研究范围的不同洞见主题。表
    8 展示了所有审查研究中涵盖的主题，这些主题囊括了本章研究问题的解决框架。
- en: Table 8\. The research themes
  id: totrans-213
  prefs: []
  type: TYPE_NORMAL
  zh: 表 8\. 研究主题
- en: '| Document type | Author | Blockchain | IoT | PP | TP | IM |'
  id: totrans-214
  prefs: []
  type: TYPE_TB
  zh: '| 文档类型 | 作者 | 区块链 | 物联网 | PP | TP | IM |'
- en: '| Academic Journal | Yong et al. (2019) | x |  |  |  | x |'
  id: totrans-215
  prefs: []
  type: TYPE_TB
  zh: '| 学术期刊 | Yong 等人 (2019) | x |  |  |  | x |'
- en: '| De Aguiar et al. (2020) | x | x |  | x | x |'
  id: totrans-216
  prefs: []
  type: TYPE_TB
  zh: '| De Aguiar 等人 (2020) | x | x |  | x | x |'
- en: '| Abbas et al. (2020) | x |  | X |  | x |'
  id: totrans-217
  prefs: []
  type: TYPE_TB
  zh: '| Abbas 等人 (2020) | x |  | X |  | x |'
- en: '| Slym et al. (2018) | x |  |  | x | x |'
  id: totrans-218
  prefs: []
  type: TYPE_TB
  zh: '| Slym 等人 (2018) | x |  |  | x | x |'
- en: '| Jamil et al. (2019) | x |  |  |  | x |'
  id: totrans-219
  prefs: []
  type: TYPE_TB
  zh: '| Jamil 等人 (2019) | x |  |  |  | x |'
- en: '| Wu et al. (2017) | x |  |  | x | x |'
  id: totrans-220
  prefs: []
  type: TYPE_TB
  zh: '| Wu 等人 (2017) | x |  |  | x | x |'
- en: '| Kumari and Saini (2020) | x |  |  |  | x |'
  id: totrans-221
  prefs: []
  type: TYPE_TB
  zh: '| Kumari 和 Saini (2020) | x |  |  |  | x |'
- en: '| Papert, Rimpler and Pflaum (2016) |  | x | X | x | x |'
  id: totrans-222
  prefs: []
  type: TYPE_TB
  zh: '| Papert，Rimpler 和 Pflaum (2016) |  | x | X | x | x |'
- en: '| Tseng et al. (2018) | x | x | X | x | x |'
  id: totrans-223
  prefs: []
  type: TYPE_TB
  zh: '| Tseng 等人 (2018) | x | x | X | x | x |'
- en: '| Radanovic and Likic (2018) | x |  |  |  | x |'
  id: totrans-224
  prefs: []
  type: TYPE_TB
  zh: '| Radanovic 和 Likic (2018) | x |  |  |  | x |'
- en: '| Pandey and Litoriya (2020) | x |  |  | x | x |'
  id: totrans-225
  prefs: []
  type: TYPE_TB
  zh: '| Pandey 和 Litoriya (2020) | x |  |  | x | x |'
- en: '| Yadav, Selva and Tandon (2020) | x | x |  |  | x |'
  id: totrans-226
  prefs: []
  type: TYPE_TB
  zh: '| Yadav，Selva 和 Tandon (2020) | x | x |  |  | x |'
- en: '| Srivastava et al. (2019) | x | x |  | x | x |'
  id: totrans-227
  prefs: []
  type: TYPE_TB
  zh: '| Srivastava 等人 (2019) | x | x |  | x | x |'
- en: '| Rotunno et al. (2014) |  | x | X |  | x |'
  id: totrans-228
  prefs: []
  type: TYPE_TB
  zh: '| Rotunno 等人 (2014) |  | x | X |  | x |'
- en: '| Dwivedi, Amin and Vollala (2020) | x | x |  |  | x |'
  id: totrans-229
  prefs: []
  type: TYPE_TB
  zh: '| Dwivedi，Amin 和 Vollala (2020) | x | x |  |  | x |'
- en: '| Chanson et al. (2018) | x | x |  |  | x |'
  id: totrans-230
  prefs: []
  type: TYPE_TB
  zh: '| Chanson 等人 (2018) | x | x |  |  | x |'
- en: '| Hasan et al. (2019) | x | x |  | x | x |'
  id: totrans-231
  prefs: []
  type: TYPE_TB
  zh: '| Hasan 等人 (2019) | x | x |  | x | x |'
- en: '| Kim and Laskowski (2018) | x | x |  |  | x |'
  id: totrans-232
  prefs: []
  type: TYPE_TB
  zh: '| Kim 和 Laskowski (2018) | x | x |  |  | x |'
- en: '| Kshetri (2018) | x |  |  |  | x |'
  id: totrans-233
  prefs: []
  type: TYPE_TB
  zh: '| Kshetri (2018) | x |  |  |  | x |'
- en: '| Conference paper | Fernando (2020) | x |  |  |  | x |'
  id: totrans-234
  prefs: []
  type: TYPE_TB
  zh: '| 会议论文 | Fernando (2020) | x |  |  |  | x |'
- en: '| Chiacchio et al. (2019) | x | x | x |  | x |'
  id: totrans-235
  prefs: []
  type: TYPE_TB
  zh: '| Chiacchio 等人 (2019) | x | x | x |  | x |'
- en: '| Alangot and Achuthan. (2017) | x | x |  |  | x |'
  id: totrans-236
  prefs: []
  type: TYPE_TB
  zh: '| Alangot 和 Achuthan。 (2017) | x | x |  |  | x |'
- en: '| Kumar and Tripathi (2019) | x |  |  |  | x |'
  id: totrans-237
  prefs: []
  type: TYPE_TB
  zh: '| Kumar 和 Tripathi (2019) | x |  |  |  | x |'
- en: '| Molina et al. (2019) | x |  |  |  | x |'
  id: totrans-238
  prefs: []
  type: TYPE_TB
  zh: '| Molina 等人 (2019) | x |  |  |  | x |'
- en: '| Sahoo et al. (2019) | x | x | x | x | x |'
  id: totrans-239
  prefs: []
  type: TYPE_TB
  zh: '| Sahoo 等人 (2019) | x | x | x | x | x |'
- en: '| Chiacchio et al. (2020) | x | x | x |  | x |'
  id: totrans-240
  prefs: []
  type: TYPE_TB
  zh: '| Chiacchio 等人 (2020) | x | x | x |  | x |'
- en: '| Jangir et al. (2019) | x |  | x |  | x |'
  id: totrans-241
  prefs: []
  type: TYPE_TB
  zh: '| Jangir 等人 (2019) | x |  | x |  | x |'
- en: '| Raj, Rai and Agarwal (2019) | x |  |  |  | x |'
  id: totrans-242
  prefs: []
  type: TYPE_TB
  zh: '| Raj，Rai 和 Agarwal (2019) | x |  |  |  | x |'
- en: '| Premkumar and C. (2020) | x | x | x | x | x |'
  id: totrans-243
  prefs: []
  type: TYPE_TB
  zh: '| Premkumar 和 C. (2020) | x | x | x | x | x |'
- en: '| Bryatov and Borodinov (2019) | x |  |  |  | x |'
  id: totrans-244
  prefs: []
  type: TYPE_TB
  zh: '| Bryatov 和 Borodinov (2019) | x |  |  |  | x |'
- en: '| Bocek et al. (2017) | x | x |  | x | x |'
  id: totrans-245
  prefs: []
  type: TYPE_TB
  zh: '| Bocek 等人 (2017) | x | x |  | x | x |'
- en: '| Kumar et al. (2019) | x |  | x |  | x |'
  id: totrans-246
  prefs: []
  type: TYPE_TB
  zh: '| Kumar 等人 (2019) | x |  | x |  | x |'
- en: '| Ahmadi et al. (2020) | x | x | x |  | x |'
  id: totrans-247
  prefs: []
  type: TYPE_TB
  zh: '| Ahmadi 等人 (2020) | x | x | x |  | x |'
- en: '| Huang, Wu and Long (2018) | x |  | x |  | x |'
  id: totrans-248
  prefs: []
  type: TYPE_TB
  zh: '| Huang，Wu 和 Long (2018) | x |  | x |  | x |'
- en: '| Ting et al. (2020) |  | x |  |  | x |'
  id: totrans-249
  prefs: []
  type: TYPE_TB
  zh: '| Ting 等人 (2020) |  | x |  |  | x |'
- en: '| Botcha, Chakravarthy and Anurag (2019) | x | x | x |  | x |'
  id: totrans-250
  prefs: []
  type: TYPE_TB
  zh: '| Botcha，Chakravarthy 和 Anurag (2019) | x | x | x |  | x |'
- en: '| Barchetti et al. (2020) |  | x | x |  | x |'
  id: totrans-251
  prefs: []
  type: TYPE_TB
  zh: '| Barchetti 等人 (2020) |  | x | x |  | x |'
- en: '| Zhou and Piramuthu (2014) |  | x |  |  | x |'
  id: totrans-252
  prefs: []
  type: TYPE_TB
  zh: '| Zhou 和 Piramuthu (2014) |  | x |  |  | x |'
- en: '| Chitre et al. (2020) | x | x | x |  | x |'
  id: totrans-253
  prefs: []
  type: TYPE_TB
  zh: '| Chitre 等人 (2020) | x | x | x |  | x |'
- en: '| Shi, Yi and Kuang (2019) | x | x | x |  | x |'
  id: totrans-254
  prefs: []
  type: TYPE_TB
  zh: '| 史一，匡（2019年） | x | x | x |  | x |'
- en: '| Benatia et al. (2018) |  | x | x |  | x |'
  id: totrans-255
  prefs: []
  type: TYPE_TB
  zh: '| Benatia等人（2018年） |  | x | x |  | x |'
- en: '| Sinclair, Shahriar and Zhang (2019) | x |  |  |  | x |'
  id: totrans-256
  prefs: []
  type: TYPE_TB
  zh: '| Sinclair，Shahriar和Zhang（2019年） | x |  |  |  | x |'
- en: '| Xie, Wang and Ye (2019) | x |  |  |  | x |'
  id: totrans-257
  prefs: []
  type: TYPE_TB
  zh: '| 谢，王和叶（2019年） | x |  |  |  | x |'
- en: '| Trade journal | Anon (2018) |  | x |  |  | x |'
  id: totrans-258
  prefs: []
  type: TYPE_TB
  zh: '| 商业杂志 | 匿名（2018年） |  | x |  |  | x |'
- en: '| Vecchione (2017) | x |  |  |  | x |'
  id: totrans-259
  prefs: []
  type: TYPE_TB
  zh: '| Vecchione（2017年） | x |  |  |  | x |'
- en: '| Thaul (2015) | x |  |  |  | x |'
  id: totrans-260
  prefs: []
  type: TYPE_TB
  zh: '| Thaul（2015年） | x |  |  |  | x |'
- en: '| Shanley (2018) |  | x | x |  | x |'
  id: totrans-261
  prefs: []
  type: TYPE_TB
  zh: '| Shanley（2018年） |  | x | x |  | x |'
- en: '| Marbury (2019) | x |  |  |  | x |'
  id: totrans-262
  prefs: []
  type: TYPE_TB
  zh: '| Marbury（2019年） | x |  |  |  | x |'
- en: '| Shanley (2017) |  | x |  | x | x |'
  id: totrans-263
  prefs: []
  type: TYPE_TB
  zh: '| Shanley（2017年） |  | x |  | x | x |'
- en: '| Haughwout (2018) | x | x |  |  | x |'
  id: totrans-264
  prefs: []
  type: TYPE_TB
  zh: '| Haughwout（2018年） | x | x |  |  | x |'
- en: '| Redman (2019) | x |  |  |  | x |'
  id: totrans-265
  prefs: []
  type: TYPE_TB
  zh: '| Redman（2019年） | x |  |  |  | x |'
- en: '| Book Chapter | Anand et al. (2020) | x |  |  |  | x |'
  id: totrans-266
  prefs: []
  type: TYPE_TB
  zh: '| 图书章节 | 阿纳德等人（2020年） | x |  |  |  | x |'
- en: '|  | Number of articles per theme | 44 | 28 | 18 | 12 | 52 |'
  id: totrans-267
  prefs: []
  type: TYPE_TB
  zh: '|  | 每个主题的文章数量 | 44 | 28 | 18 | 12 | 52 |'
- en: 'Note: IM =information management'
  id: totrans-268
  prefs: []
  type: TYPE_NORMAL
  zh: 注意：IM = 信息管理
- en: PP = Package process
  id: totrans-269
  prefs: []
  type: TYPE_NORMAL
  zh: PP = 包装流程
- en: TP = Transport process
  id: totrans-270
  prefs: []
  type: TYPE_NORMAL
  zh: TP = 运输流程
- en: THEMATIC ANALYSIS
  id: totrans-271
  prefs: []
  type: TYPE_NORMAL
  zh: 主题分析
- en: This section provides a detailed analysis of the findings from the reviewed
    articles. It is confirmed from the reviewed articles that the IoT and blockchain
    have enormous potential for resolving existing problems in the PSC and creating
    a traceable, transparent and authentic pharmaceutical supply environment. Before
    analyzing the thematic contribution, it would be helpful to understand the current
    challenges and problems in the current PSC. Therefore, this section would start
    with the findings related to traditional PSC followed by a discussion of findings
    categorized into two main themes, which are application and opportunities of IoT
    and blockchain technologies in PSC. Finally, the combination strategy of the IoT
    and blockchain is discussed in the context of PSC.
  id: totrans-272
  prefs: []
  type: TYPE_NORMAL
  zh: 本节提供了对审查文章所得结果的详细分析。审查文章确认了物联网和区块链在解决当前PSC中存在的问题并创建可追溯、透明和真实的制药供应环境方面具有巨大潜力。在分析主题贡献之前，了解当前PSC中的挑战和问题将是有帮助的。因此，本节将从与传统PSC相关的发现开始，然后讨论分为物联网和区块链技术在PSC中的应用和机会两个主要主题的发现，并最终在PSC背景下讨论物联网和区块链的组合策略。
- en: Traditional Pharmaceutical Supply Chain
  id: totrans-273
  prefs: []
  type: TYPE_NORMAL
  zh: 传统制药供应链
- en: Challenges in Traditional PSC
  id: totrans-274
  prefs: []
  type: TYPE_NORMAL
  zh: 传统PSC中的挑战
- en: 'There are several participants involved in the PSC, as a result it becomes
    complex in today’s business world. Recent studies indicated that pharmaceutical
    industries are facing challenges. There are many challenges but three universal
    challenges in the PSC are discussed below:'
  id: totrans-275
  prefs: []
  type: TYPE_NORMAL
  zh: 有许多参与者参与了PSC，因此在今天的商业世界中变得复杂。最近的研究表明，制药行业面临着挑战。有许多挑战，但以下是PSC中的三个普遍挑战：
- en: Poor Product Traceability
  id: totrans-276
  prefs: []
  type: TYPE_NORMAL
  zh: 产品追溯不足
- en: Insufficient drug traceability is one of the issues that has been in existence
    for a long time. There are several published studies which defined this problem
    as an immense challenge in PSC (Sahoo et al., 2019; Dwivedi, Amin and Vollala,
    2020). Traceability is crucial in guaranteeing that the drugs have complied with
    the regulations and products are delivered to end customers safely (Dwivedi, Amin
    and Vollala, 2020). It is also the basis for customer confidence building in the
    pharmaceutical market (Chiacchio et al., 2019). However, Kim and Laskowski (2018)
    explained that pharmaceutical provenance evaluation in today’s PSC is complex
    because of its inter-organizational nature. Furthermore, Srivastava et al. (2019)
    pointed out that the unsatisfactory information sharing, information transmission
    delay and inefficient drug traceability system made it hard to track drugs and
    ensure the provenance and authenticity.
  id: totrans-277
  prefs: []
  type: TYPE_NORMAL
  zh: 不足的药物追溯是长期存在的问题之一。有几项已发表的研究将这一问题定义为PSC中的一个巨大挑战（Sahoo等人，2019年；Dwivedi，Amin和Vollala，2020年）。追溯对于确保药品符合法规并安全地交付给最终客户至关重要（Dwivedi，Amin和Vollala，2020年）。这也是制药市场建立客户信心的基础（Chiacchio等人，2019年）。然而，金和拉斯科夫斯基（2018年）解释说，今天的PSC中药品的来源评估是复杂的，因为它具有跨组织性质。此外，斯里瓦斯塔瓦等人（2019年）指出，信息共享不足、信息传输延迟和药物追溯系统效率低下导致了难以追踪药品和确保来源和真实性。
- en: As for the present track and trace system in PSC, Chitre et al. (2019) indicated
    that drug traceability could be achieved by integrating IT systems from manufacturers
    to retailers. Although this practice is in compliance with the regulations related
    to traceability, however, there are some concerns in the adoption of such a system.
    Firstly, as Pandey and Litoriya (2020) mentioned, this is a centralized system
    that might occur as a single point of failure. Yong et al. (2020), Kumari and
    Saini (2020) also suggested the same opinion that the centralized information
    system is risky. At the same time, they underlined that data is highly prone to
    be deleted or tampered when the central server is attacked. Secondly, all the
    transactions data is stored in a database managed by a third-party that would
    decrease the privacy and reliability of records as the middleman could obtain
    and modify drug information easily (Huang, Wu and Long, 2018; Chitre et al., 2019).
    Thirdly, end-users are out of the system. According to the studies by Chitre et
    al. (2019) and Pandey (2020), the record processing usually starts from the manufacturer
    and end before reaching the end-users. Furthermore, manual operations are involved
    in current data collection and sharing mechanisms, where human error might occur
    (Ting et al., 2010). Hence, the present systems have some shortcomings including
    data security, data transparency, data transmission delays, poor compatibility
    of the IT systems. They could not meet the demand for tracking and tracing of
    drugs.
  id: totrans-278
  prefs: []
  type: TYPE_NORMAL
  zh: 至于PSC中现有的追踪系统，Chitre等人（2019年）指出，药品追溯可以通过将制造商到零售商的IT系统集成来实现。尽管这一做法符合追溯相关的法规，但对这种系统的采用仍存在一些担忧。首先，正如Pandey和Litoriya（2020年）所指出的，这是一个集中式系统，可能会出现单点故障。Yong等人（2020年）、Kumari和Saini（2020年）也提出了相同的观点，即集中式信息系统存在风险。同时，他们强调，当中央服务器受到攻击时，数据很容易被删除或篡改。其次，所有交易数据存储在由第三方管理的数据库中，这会降低记录的隐私性和可靠性，因为中间人可以轻易获取和修改药品信息（Huang、Wu和Long，2018年；Chitre等人，2019年）。第三，最终用户不在系统之内。根据Chitre等人（2019年）和Pandey（2020年）的研究，记录处理通常从制造商开始，到达最终用户之前结束。此外，目前的数据收集和共享机制涉及手动操作，可能会发生人为错误（Ting等人，2010年）。因此，目前的系统存在一些缺点，包括数据安全性、数据透明度、数据传输延迟、IT系统兼容性差。它们无法满足药品追踪的需求。
- en: Low Transparency
  id: totrans-279
  prefs: []
  type: TYPE_NORMAL
  zh: 低透明度
- en: The lack of transparency is another major issue in the current complex PSC.
    Several publications indicated this problem, such as Tseng et al. (2018), Kumari
    and Saini (2020), as well as Dwivedi, Amin and Vollala (2020). Jamil et al. (2019)
    mentioned that low transparency related to information and transaction. The root
    cause of the low transparency is the absence of an appropriate information transmission
    system or mechanism. Currently, different enterprises might use different systems
    to record information, which would lead to a problem with compatibility (Dwivedi,
    Amin and Vollala, 2020). In this situation, it is hard to guarantee the integrity
    and timeliness of the information flow. The missing data, information asymmetry,
    or block would lead to a non-transparent supply chain (Tseng et al., 2018). In
    addition, although the development of information technology allows the integration
    of different kinds of IT system, but there is still a risk of poor product traceability.
  id: totrans-280
  prefs: []
  type: TYPE_NORMAL
  zh: 目前复杂的PSC中透明度不足是另一个主要问题。几篇出版物指出了这个问题，比如Tseng等人（2018年）、Kumari和Saini（2020年），以及Dwivedi、Amin和Vollala（2020年）。Jamil等人（2019年）提到了低透明度与信息和交易相关。低透明度的根本原因是缺乏适当的信息传递系统或机制。目前，不同企业可能使用不同的系统记录信息，这会导致兼容性问题（Dwivedi、Amin和Vollala，2020年）。在这种情况下，很难保证信息流的完整性和及时性。缺失的数据、信息不对称或阻塞会导致供应链不透明（Tseng等人，2018年）。此外，尽管信息技术的发展允许集成不同类型的IT系统，但产品追溯仍存在风险。
- en: The low transparency and visibility would have some bad effects on PSC management
    since there are gaps where fake drugs may be introduced into the market (Shi,
    Yi and Kuang, 2019; Abbas et al., 2020). At the same time, the low transparency
    in PSC would result in a low trust relationship between partners (Thaul, 2015;
    Jangir et al., 2019). Fernando, Meyliana and Surjandy (2019) emphasized on maintaining
    the trust relationship among different types of companies, which is consistent
    with the view of Dwivedi (2020), Chitre et al. (2019), and Ting et al. (2010).
    Lacking trust in PSC would greatly hinder cooperation and collaboration between
    partners.
  id: totrans-281
  prefs: []
  type: TYPE_NORMAL
  zh: 透明度和可见性低会对 PSC 管理产生一些不良影响，因为存在可能将假药引入市场的漏洞（Shi、Yi 和 Kuang，2019年；Abbas 等人，2020年）。与此同时，PSC
    中的低透明度会导致合作伙伴之间的信任关系降低（Thaul，2015年；Jangir 等人，2019年）。Fernando、Meyliana 和 Surjandy（2019年）强调了在不同类型公司之间保持信任关系的重要性，这与
    Dwivedi（2020年）、Chitre 等人（2019年）和 Ting 等人（2010年）的观点一致。在 PSC 中缺乏信任将极大地阻碍合作和协作关系的发展。
- en: In order to alleviate the transparency, visibility and traceability issues,
    there are some monitoring technologies that have been suggested to collect data
    in recent years. Barcode, QR code, RFID are relatively mature identification technologies
    adopted in the PSC, despite their capabilities being somewhat limited (Barchetti
    et al., 2010; Papert, Rimpler and Pflaum, 2016a; Hasan et al., 2019). From previous
    literature, it could be seen that such identification technologies could help
    to offer a degree of information visibility and transparency in PSC but at the
    risks of privacy, wireless attacks, modifying and reusing of data (Jamil et al.,
    2019; Kumar and Tripathi, 2019; Dwivedi, Amin and Vollala, 2020).
  id: totrans-282
  prefs: []
  type: TYPE_NORMAL
  zh: 为了减轻透明度、可见性和可追溯性问题，近年来有一些监测技术被提出用于收集数据。条形码、QR 码、RFID 是在 PSC 中采用的相对成熟的识别技术，尽管它们的能力有些受限（Barchetti
    等人，2010年；Papert、Rimpler 和 Pflaum，2016a；Hasan 等人，2019年）。从先前的文献中可以看出，这些识别技术可以帮助在
    PSC 中提供一定程度的信息可见性和透明度，但存在隐私、无线攻击、数据修改和重用的风险（Jamil 等人，2019年；Kumar 和 Tripathi，2019年；Dwivedi、Amin
    和 Vollala，2020年）。
- en: In the aspect of identification capability, barcode can only define one kind
    of product, which is disadvantageous for PSC (Ting et al., 2010). As for the read
    and write capability, data in the barcode and data matrix code is fixed. Both
    of these two techniques do not support adding further information at the drug
    level (Papert, Rimpler and Pflaum, 2016). Moreover, in the view of the read range,
    the barcode requires a laser beam to scan without any obstacles. The broken or
    polluted barcode could not be identified (Ting et al., 2010). On the other hand,
    RFID has more advantages, Ting et al. (2010) indicated that RFID allows the assignment
    of unique ID to each item, which is beneficial in tracking specific products.
    Furthermore, the read range of RFID technology is also longer than the barcode
    and is not limited by an obstacle. However, the popularity of the RFID system
    is not very high (Molina, Delgado and Tarazona, 2019). In addition, Raj, Rai and
    Agarwal (2019) and Kumar (2019) noted that RFID and QR code can be imitated and
    cloned easily with the growing skills and techniques, which also poses a threat
    to authenticity of data in PSC.
  id: totrans-283
  prefs: []
  type: TYPE_NORMAL
  zh: 在识别能力方面，条形码只能定义一种产品，这对 PSC 不利（Ting 等人，2010年）。至于读写能力，条形码和数据矩阵码中的数据是固定的。这两种技术都不支持在药品级别上添加更多信息（Papert、Rimpler
    和 Pflaum，2016年）。此外，在读取范围方面，条形码需要激光束扫描，而且不能有任何障碍。损坏或污染的条形码无法被识别（Ting 等人，2010年）。另一方面，RFID
    具有更多优势，Ting 等人（2010年）指出，RFID 允许为每个项目分配唯一的 ID，有利于跟踪特定产品。此外，RFID 技术的读取范围也比条形码长，并且不受障碍限制。然而，RFID
    系统的普及率并不是很高（Molina、Delgado 和 Tarazona，2019年）。此外，Raj、Rai 和 Agarwal（2019年）以及 Kumar（2019年）指出，随着技能和技术的增长，RFID
    和 QR 码很容易被模仿和克隆，这也对 PSC 中数据的真实性构成了威胁。
- en: The Lack of Authenticity
  id: totrans-284
  prefs: []
  type: TYPE_NORMAL
  zh: 真实性的缺乏
- en: The authenticity of drugs in current complex PSC is hard to ensure as there
    are several distribution channels for drugs, which involves multiple processes
    and enterprises. The most challenging issue about authenticity is drug counterfeiting.
    Several publications documented that counterfeit and fake drug is a major threat
    to the pharmaceutical industry (Tseng et al., 2018; Jamil et al., 2019; Kumari
    and Saini, 2020; Pandey and Litoriya, 2020). It is prevalent in the developing
    countries and in the areas that lack strict surveillance (Sylim et al., 2018;
    Pandey and Litoriya, 2020). The quality of fictitious drugs is poor and non-standard,
    which would have a negative effect on consumer’s health (Abbas et al., 2020).
    At the same time, this kind of phenomenon would cause low public confidence in
    the effectiveness of the authentic drugs, influence the reputation of the companies
    in the PSC, as well as it leads to revenue losses of the medical company (Papert,
    Rimpler and Pflaum, 2016; Sahoo et al., 2019).
  id: totrans-285
  prefs: []
  type: TYPE_NORMAL
  zh: 在当前复杂的PSC中，药物的真实性难以保证，因为药物有多个分销渠道，涉及多个流程和企业。关于真实性的最大挑战是药物伪造。几篇文献记载了伪造和假药对制药行业的重大威胁（Tseng等，2018年；Jamil等，2019年；Kumari和Saini，2020年；Pandey和Litoriya，2020年）。它在发展中国家和缺乏严格监管的地区很普遍（Sylim等，2018年；Pandey和Litoriya，2020年）。虚假药的质量差，不规范，会对消费者的健康产生负面影响（Abbas等，2020年）。同时，这种现象会降低公众对真正药物有效性的信心，影响PSC公司的声誉，以及导致医药公司的收入损失（Papert，Rimpler和Pflaum，2016年；Sahoo等，2019年）。
- en: Some researchers have argued that the appearance of fake drugs was due to low
    transparency and visibility in the current PSC (Shi, Yi and Kuang, 2019; Kumar
    et al., 2019; Abbas et al., 2020). Although some technologies such as barcode
    and RFID have already been implemented in PSC, they could not prevent counterfeit
    drugs in the market and ensure the authenticity of the products effectively (Papert,
    Rimpler and Pflaum, 2016; Tseng et al., 2018; Anand et al., 2020).
  id: totrans-286
  prefs: []
  type: TYPE_NORMAL
  zh: 一些研究人员认为，假药的出现是由于当前PSC的透明度和可见度较低（Shi，Yi和Kuang，2019年；Kumar等，2019年；Abbas等，2020年）。尽管一些技术，如条形码和RFID已经在PSC中实施，但它们无法阻止市场上的假药，并有效确保产品的真实性（Papert，Rimpler和Pflaum，2016年；Tseng等，2018年；Anand等，2020年）。
- en: Another problem related to PSC authenticity is information records. Molina,
    Delgado and Tarazona (2019) described that every participant in PSC has different
    tasks and each enterprise has its own information and IT system. Because of the
    IT system compatibility issue, participants of PSC exchange information through
    paper-based records. Another method is using a centralized database management
    by a third-party. Moreover, there is a possibility of fabrication and tampering
    of a centralized database maintained by an intermediary (Huang, Wu and Long, 2018).
    These potential risks pose a threat to authenticity and efficient government supervision,
    which might even cause serious security issues.
  id: totrans-287
  prefs: []
  type: TYPE_NORMAL
  zh: 与PSC真实性相关的另一个问题是信息记录。 Molina，Delgado和Tarazona（2019年）描述了PSC中的每个参与者都有不同的任务，每个企业都有自己的信息和IT系统。由于IT系统的兼容性问题，PSC的参与者通过纸质记录交换信息。另一种方法是通过第三方进行集中式数据库管理。此外，由中介维护的集中式数据库可能存在捏造和篡改的可能性（Huang，Wu和Long，2018年）。这些潜在风险对真实性和有效的政府监督构成了威胁，甚至可能引发严重的安全问题。
- en: Limitations and Requirements
  id: totrans-288
  prefs: []
  type: TYPE_NORMAL
  zh: 限制和要求
- en: Based on the comprehensive analysis of the current PSC situation, present technologies
    and IT support systems, it could be seen that those current practices and adopted
    techniques are inadequate for achieving the target of traceability, transparency
    and authenticity in PSC. Thus, as highlighted by Abbas et al., (2020), Yong et
    al. (2020) and Kumar and Tripathi (2019), there is need to develop a trustworthy
    and tamper proof information network to help address the issues and challenges
    in current PSC. Such a network is required to record and share information related
    to drugs accurately and securely from its raw material suppliers through manufacturers
    and wholesalers to end-users (Huang, Wu and Long, 2018; Pandey and Litoriya, 2020).
    Meanwhile, it requires that the network offer higher visibility and transparency
    to the government regulator, as well as, gives assistance in drug traceability
    in a complex international PSC to prove the provenance of medicine (Kim and Laskowski,
    2018a; Kim and Laskowski, 2018a).
  id: totrans-289
  prefs: []
  type: TYPE_NORMAL
  zh: 基于对当前 PSC 情况、现有技术和 IT 支持系统的全面分析，可以看出，目前的做法和采用的技术不足以实现 PSC 中的可追溯性、透明度和真实性目标。
    因此，正如 Abbas 等人（2020）、Yong 等人（2020）和 Kumar 和 Tripathi（2019）所强调的，有必要开发一个值得信赖且防篡改的信息网络，以帮助解决当前
    PSC 中的问题和挑战。 这样的网络需要准确、安全地记录和共享与药品有关的信息，从其原材料供应商、制造商和批发商到最终用户（Huang、Wu 和 Long，2018；Pandey
    和 Litoriya，2020）。 与此同时，它要求网络对政府监管机构提供更高的可见性和透明度，并在复杂的国际 PSC 中协助药品可追溯性，以证明药品的来源（Kim
    和 Laskowski，2018a；Kim 和 Laskowski，2018a）。
- en: Applying IoT and Blockchain in PSC
  id: totrans-290
  prefs: []
  type: TYPE_NORMAL
  zh: 在 PSC 中应用 IoT 和区块链
- en: IoT Technology in PSC
  id: totrans-291
  prefs: []
  type: TYPE_NORMAL
  zh: IoT 技术在 PSC 中
- en: IoT Application
  id: totrans-292
  prefs: []
  type: TYPE_NORMAL
  zh: IoT 应用
- en: IoT implementation is on the basis of the emergence of IoT sensors or tags like
    loggers, RFID, barcode and QR code, etc. (Xu et al.,2014). As mentioned earlier,
    barcode, QR code, and RFID are identification technologies adopted in the current
    PSC, which could help PSC to identify goods quickly and offer a degree of information
    visibility.
  id: totrans-293
  prefs: []
  type: TYPE_NORMAL
  zh: IoT 的实施是基于 IoT 传感器或标签的出现，如记录器、RFID、条形码和 QR 码等（Xu 等人，2014）。 正如前文所述，条形码、QR 码和RFID
    是当前 PSC 中采用的识别技术，它们可以帮助 PSC 快速识别货物并提供一定程度的信息可见性。
- en: In addition, the serialization is an IoT technology. It was identified as the
    anti-counterfeit solution when the EU published a regulation that all Rx products
    (prescription drugs) must have a safety label supporting verification check in
    the whole PSC (Chiacchio et al., 2020). According to the description of Chiacchio
    (2020), it requires the allocation of a unique serial number linked to drug production
    data such as batch number, production data and item identification code in the
    form of data matrix code, and then label the number on the drug package. With
    the unique identifier and the hierarchy matrix from the serialization software,
    the drug could be tracked from the outer to the inner package level. Currently,
    advanced technology enables operation machines to generate a serial number, print
    labels, packing automatically, as well as connect with the Internet to realize
    the IoT paradigm (Chiacchio et al., 2019, Jha et al., 2019).
  id: totrans-294
  prefs: []
  type: TYPE_NORMAL
  zh: 此外，序列化是一种 IoT 技术。 当欧盟发布法规要求所有处方药产品（处方药）必须具有支持整个 PSC 中的验证检查的安全标签时，它被确定为防伪解决方案（Chiacchio
    等人，2020）。 根据 Chiacchio（2020）的描述，它需要分配一个与药品生产数据（如批号、生产日期和项目识别代码）相关联的唯一序列号，以数据矩阵码的形式，然后将该号码贴在药品包装上。
    通过序列化软件的唯一标识符和层次矩阵，可以从外部追踪药品到内部包装级别。 目前，先进的技术使操作机器能够自动生成序列号、打印标签、自动包装，并与互联网连接以实现
    IoT 范例（Chiacchio 等人，2019；Jha 等人，2019）。
- en: Opportunities for IoT
  id: totrans-295
  prefs: []
  type: TYPE_NORMAL
  zh: IoT 的机遇
- en: According to IoT application, different kinds of IoT sensors can capture detailed
    real-time data related to the environment, products and locations as well as timestamps
    (Shanley, 2017; Kim and Laskowski, 2018b; Chanson et al., 2019). Therefore, the
    emergence of IoT technology in supply chain management is in favor of providing
    digital footprints and building a real-time information communication and product
    monitoring network (DE AGUIAR et al., 2020; Premkumar and C, 2020, Khari et al.,
    2019). With real-time sharing, the network could support to integrate partners
    (Xie et al., 2019). A similar opinion was provided by Srivastava et al. (2019)
    that the combination of sensor and network enables data exchanges between objectives
    and mechanism. As mentioned before, the IoT sensors like RFID, QR Code were adopted
    frequently to collect and provide a large amount of data in PSC, which could help
    to provide the digital footprints of drugs through PSC. However, some new challenges
    related to security and privacy have been brought by the usage of IoT devices,
    as indicated by Chanson et al. (2019).
  id: totrans-296
  prefs: []
  type: TYPE_NORMAL
  zh: 根据物联网应用，不同种类的物联网传感器可以捕捉与环境、产品和位置以及时间戳相关的详细实时数据（Shanley，2017；Kim和Laskowski，2018b；Chanson等，2019）。因此，物联网技术在供应链管理中的出现有利于提供数字足迹并构建实时信息通信和产品监控网络（DE
    AGUIAR等，2020年；Premkumar和C，2020年；Khari等，2019年）。通过实时共享，网络可以支持整合合作伙伴（Xie等，2019年）。Srivastava等人（2019年）提供了类似的观点，即传感器和网络的结合使目标和机制之间的数据交换成为可能。正如前面提到的，物联网传感器如RFID、QR码经常被采用来收集和提供大量的PSC数据，这有助于通过PSC提供药品的数字足迹。然而，正如Chanson等人（2019年）所指出的，物联网设备的使用带来了一些与安全和隐私有关的新挑战。
- en: Blockchain Technology in PSC
  id: totrans-297
  prefs: []
  type: TYPE_NORMAL
  zh: PSC中的区块链技术
- en: Blockchain Application
  id: totrans-298
  prefs: []
  type: TYPE_NORMAL
  zh: 区块链应用
- en: A PSC management system based on Hyperledger fabrics was developed in the study
    of Abbas et al. (2020) to solve the problems of fraud vaccine record and expired
    vaccines. Companies involved in the PSC from raw material to final clients are
    included as participants in the system. The authors in their study indicated that
    the simulation results were satisfactory. In the same year, another blockchain-based
    system was designed. Smart contracts were developed in the vaccine Ethereum blockchain
    for supervision (Yong et al., 2020), which could provide a tamper proof environment
    for tracking vaccines. However, the research only chose three key institutions
    to join the network, which does not correspond with the actual situation. In addition,
    the system for tracking and checking the delivery process was provided by Molina,
    Delgado and Tarazona (2019). The system adopted Hyperledger blockchain technology.
    However, this approach was just based on the case study, and may not be practical.
    Jamil et al. (2019) recommended a novel and secure system for documenting medicine
    supply chain records by using Hyperledger Fabric blockchain.
  id: totrans-299
  prefs: []
  type: TYPE_NORMAL
  zh: 在Abbas等人（2020年）的研究中开发了基于Hyperledger Fabrics的PSC管理系统，以解决欺诈疫苗记录和过期疫苗的问题。从原材料到最终客户的参与PSC的公司都包括在系统中。作者在他们的研究中指出，模拟结果是令人满意的。同一年，另一个基于区块链的系统被设计出来了。智能合约在疫苗以太坊区块链中被开发出来进行监督（Yong等，2020年），这可以为追踪疫苗提供一个防篡改的环境。然而，该研究只选择了三个关键机构加入网络，这与实际情况不符。此外，Molina、Delgado和Tarazona（2019年）提供了一个用于跟踪和检查交付过程的系统。该系统采用了Hyperledger区块链技术。然而，这种方法只是基于案例研究，并可能不实际。Jamil等人（2019年）建议通过使用Hyperledger
    Fabric区块链来记录医药供应链记录的一种新颖且安全的系统。
- en: 'It could be found that there are two kinds of blockchain platforms, which are
    Hyperledger fabrics and Ethereum platforms. There are some differences between
    these two platforms. The above studies showed that both of two platforms are feasible
    in improving PSC. Pharmaceutical companies could choose the appropriate platform
    according to the requirements to develop a system. Differences between the two
    platforms are summarized below:'
  id: totrans-300
  prefs: []
  type: TYPE_NORMAL
  zh: 可以发现有两种区块链平台，分别是Hyperledger Fabrics和以太坊平台。这两种平台之间存在一些差异。上述研究表明，这两种平台都可行于改进PSC。制药公司可以根据需求选择合适的平台来开发系统。以下是两个平台之间的差异总结：
- en: 1\. Ethereum platform
  id: totrans-301
  prefs:
  - PREF_UL
  type: TYPE_NORMAL
  zh: 1\. 以太坊平台
- en: Ethereum is a public network with an available framework that anyone could develop
    and use as decentralized applications (Yong et al., 2020). De Aguiar et al. (2020)
    underlined the framework of Ethereum that could offer a platform to support smart
    contracts, which could create a more reliable and secure flexible environment
    for transactions. Moreover, it usually comes with data encryption as a default
    (Sylim et al., 2018a).
  id: totrans-302
  prefs: []
  type: TYPE_NORMAL
  zh: 以太坊是一个公共网络，任何人都可以开发和使用作为分布式应用程序的可用框架（Yong等，2020）。 De Aguiar等人（2020）强调了以太坊的框架可以为智能合约提供支持的平台，这可以为交易创建更可靠和安全的灵活环境。此外，它通常默认带有数据加密（Sylim等人，2018a）。
- en: 2\. Hyperleger fabric platform
  id: totrans-303
  prefs:
  - PREF_UL
  type: TYPE_NORMAL
  zh: 2\. 超级账本（Hyperledger Fabric）平台
- en: Hyperleger fabric is a private network, which could provide better performance
    and privacy as the platform is modularized and only authorized participants could
    trust and access the system (Sylim et al., 2018a; Kumar and Tripathi, 2019). Yadav,
    Selva and Tandon (2020) indicated private blockchain could be the convincing use
    case of the PSC.
  id: totrans-304
  prefs: []
  type: TYPE_NORMAL
  zh: 超级账本是一个私有网络，由于平台模块化，只有授权参与者才能信任和访问系统，因此可以提供更好的性能和隐私（Sylim等，2018a; Kumar和Tripathi，2019）。
    Yadav、Selva和Tandon（2020）指出私有区块链可能是PSC的令人信服的用例。
- en: Opportunities of Blockchain
  id: totrans-305
  prefs: []
  type: TYPE_NORMAL
  zh: 区块链的机遇
- en: The advantages of blockchain have made it an attractive technology in recent
    years. The blockchain owns many great strengths such as decentralization, time-stamped,
    data immutability, transparency and privacy, etc. (Xie et al., 2019; Chanson et
    al., 2019; De Aguiar et al., 2020). Ever-increasing studies also discussed the
    potential benefits that blockchains could bring to PSC.
  id: totrans-306
  prefs: []
  type: TYPE_NORMAL
  zh: 区块链的优势使其成为近年来一项引人注目的技术。区块链拥有许多强大的优势，如去中心化、时间戳、数据不可变性、透明度和隐私等（Xie等，2019; Chanson等，2019;
    De Aguiar等，2020）。越来越多的研究也讨论了区块链可能为PSC带来的潜在好处。
- en: 1\. Transparency and visibility
  id: totrans-307
  prefs:
  - PREF_UL
  type: TYPE_NORMAL
  zh: 1\. 透明度和可见性
- en: Studies conducted by Abbas et al. (2020), Jangir et al. (2019) and Yadav, Selva
    and Tandon (2020) mentioned that the features of distributed storage mode and
    decentralization could improve the visibility and transparency of PSC. The decentralized
    ledger enables data and transactions to be stored and shared by all network participants
    without the use of middleman (Radanović and Likić, 2018; Redman, 2019; Molina,
    Delgado and Tarazona, 2019). The end-to-end visibility enables consistent monitoring,
    thereby improving the supervision of end-to-end PSC (Dwivedi, Amin and Vollala,
    2020).
  id: totrans-308
  prefs: []
  type: TYPE_NORMAL
  zh: 由Abbas等人（2020）、Jangir等人（2019）和Yadav、Selva和Tandon（2020）进行的研究表明，分布式存储模式和去中心化的特性可以提高PSC的可见性和透明度。去中心化账本使数据和交易能够由所有网络参与者存储和共享，无需中间人（Radanović和Likić，2018;
    Redman，2019; Molina、Delgado和Tarazona，2019）。端到端的可见性使监测保持一致，从而改善了端到端PSC的监管（Dwivedi、Amin和Vollala，2020）。
- en: 2\. Traceability
  id: totrans-309
  prefs:
  - PREF_UL
  type: TYPE_NORMAL
  zh: 2\. 追溯性
- en: The connection of each block with timestamp ensures that records in blockchain
    are in strict order. Therefore, it could provide the information provenance and
    keep track of drugs in PSC (Dwivedi, Amin and Vollala, 2020b). Moreover, this
    nature could provide convincing evidence for investigation if there are any deviations
    or problems during the drug distribution process (Fernando, Meyliana and Surjandy,
    2019).
  id: totrans-310
  prefs: []
  type: TYPE_NORMAL
  zh: 每个区块与时间戳的连接确保了区块链中记录的严格顺序。因此，它可以提供信息溯源，并跟踪PSC中的药品（Dwivedi、Amin和Vollala，2020b）。此外，这一特性可以为调查提供令人信服的证据，如果在药品分销过程中出现任何偏差或问题的话（Fernando、Meyliana和Surjandy，2019）。
- en: 3\. Security and privacy
  id: totrans-311
  prefs:
  - PREF_UL
  type: TYPE_NORMAL
  zh: 3\. 安全和隐私
- en: Yong et al. (2020) and Srivastava et al. (2019) added that the blockchain could
    be a solution to tackle the barriers of privacy and security in PSC as the blocks
    are tied through cryptographic hashing and the data could be accessed by having
    specific permission. Transactions are stored in a block with a unique hash value,
    each block in the framework is always connected with the previous one (Marbury,
    2019; Ting et al., 2010). Any change is impossible in blockchain as it would cause
    a disharmony situation, and the resultant change would not be accepted by the
    network (Jangir et al., 2019; Pandey and Litoriya, 2020). So, data in the blockchain
    is immutable and tamper proof, which is beneficial to deal with the problems of
    authenticity and security to ensure the drug quality and reliability (Abbas et
    al., 2020) Moreover, the decentralization could improve the network safety and
    decrease the possibility of network failure effectively, since data is distributed
    in many nodes and is also updated in real-time (Molina, Delgado and Tarazona,
    2019; Kumari and Saini, 2020).
  id: totrans-312
  prefs: []
  type: TYPE_NORMAL
  zh: Yong等人（2020年）和Srivastava等人（2019年）补充说，区块链可以作为解决PSC中隐私和安全障碍的解决方案，因为区块通过密码哈希相连，并且只有具有特定权限的用户才能访问数据。交易被存储在具有唯一哈希值的块中，框架中的每个块都始终与前一个块连接在一起（Marbury，2019年；Ting等人，2010年）。在区块链中任何变更都是不可能的，因为它会导致不和谐的情况，并且网络不会接受结果变化（Jangir等人，2019年；Pandey和Litoriya，2020年）。因此，区块链中的数据是不可变的和防篡改的，这有助于解决真实性和安全性问题，以确保药品质量和可靠性（Abbas等人，2020年）。此外，去中心化可以提高网络安全性，有效降低网络故障的可能性，因为数据分布在许多节点中，并且也在实时更新（Molina、Delgado和Tarazona，2019年；Kumari和Saini，2020年）。
- en: 4\. Smart contract application
  id: totrans-313
  prefs:
  - PREF_UL
  type: TYPE_NORMAL
  zh: 4\. 智能合约应用
- en: Sylim et al. (2018) and Chiacchio et al. (2020) indicated the smart contract
    is the best application of blockchain that could bring several benefits to PSC.
    Firstly, Xie et al. (2019), Srivastava et al. (2019) and Fernando, Meyliana and
    Surjandy (2019) pointed out the smart contracts support in executing transaction
    verification without middleman automatically prevent various attacks in PSC, such
    as deviation, counterfeiting and theft. Secondly, the smart contracts could be
    written into the blockchain as a digital format, which enables partners in the
    same business to follow the defined rules (Chiacchio et al., 2020). Third, with
    an appropriate smart contract, the system could provide a more reliable, secure
    and flexible environment for transactions (Markarian, 2018; Sylim et al., 2018).
  id: totrans-314
  prefs: []
  type: TYPE_NORMAL
  zh: Sylim等人（2018年）和Chiacchio等人（2020年）指出，智能合约是区块链的最佳应用，可以为PSC带来多种好处。首先，谢等人（2019年），Srivastava等人（2019年）和Fernando、Meyliana和Surjandy（2019年）指出，智能合约在执行交易验证方面的支持自动防止了PSC中的各种攻击，例如偏差、伪造和盗窃。其次，智能合约可以以数字格式写入区块链中，这使得同一业务中的合作伙伴能够遵循定义的规则（Chiacchio等人，2020年）。第三，通过适当的智能合约，系统可以为交易提供更可靠、安全和灵活的环境（Markarian，2018年；Sylim等人，2018年）。
- en: 5\. Other benefits
  id: totrans-315
  prefs:
  - PREF_UL
  type: TYPE_NORMAL
  zh: 5\. 其他好处
- en: In addition to the above-mentioned features, other characteristics could also
    bring benefits to PSC. For instance, the consensus algorithm in blockchain could
    avoid the problem of the duplicate transaction and it ensures that only the validated
    information could be uploaded into the network (Abbas et al., 2020).
  id: totrans-316
  prefs: []
  type: TYPE_NORMAL
  zh: 除了上述特征之外，其他特性也可能给PSC带来好处。例如，区块链中的共识算法可以避免重复交易的问题，并确保只有经过验证的信息才能上传到网络中（Abbas等人，2020年）。
- en: Combination of IoT and Blockchain in PSC
  id: totrans-317
  prefs: []
  type: TYPE_NORMAL
  zh: '[物联网（IoT）与区块链在PSC中的结合](https://wiki.example.org/combination_of_iot_and_blockchain_in_psc)'
- en: In recent years, great effort has been devoted to the study of IoT and blockchain
    technology. Previous publications mentioned properties of blockchain which are
    useful to mitigate issues of data privacy and security in IoT (Shanley, 2018;
    Chanson et al., 2019). With blockchain, IoT could have many versatile and decentralized
    platforms, and therefore IoT could execute the works better (Dwivedi, Amin and
    Vollala, 2020a). De Aguiar et al. (2020) mentioned that blockchain could assist
    in managing and sharing the information from IoT in the healthcare area. Similarly,
    Sylim et al. (2018) and Haughwout (2018) underlined blockchain that could be a
    channel for integrating the anti-counterfeit mechanisms into the IoT and improve
    the interoperability of different unrelated systems. De Aguiar et al. (2020) and
    Ahmadi et al. (2020) also pointed out that integrating blockchain and IoT could
    offer capabilities of un-forgeability and trackability, which would help to decrease
    the possibility of drug diversion and theft.
  id: totrans-318
  prefs: []
  type: TYPE_NORMAL
  zh: 近年来，人们致力于研究物联网和区块链技术。先前的出版物提到了区块链的属性，这些属性对于缓解物联网中的数据隐私和安全问题很有用（Shanley，2018；Chanson等人，2019）。借助区块链，物联网可以拥有许多多功能和分散式的平台，因此物联网可以更好地执行工作（Dwivedi、Amin和Vollala，2020a）。De
    Aguiar等人（2020）提到，区块链可以帮助管理和共享医疗保健领域的物联网信息。同样，Sylim等人（2018）和Haughwout（2018）强调了区块链可以成为将防伪机制整合到物联网中并提高不相关系统的互操作性的渠道。De
    Aguiar等人（2020）和Ahmadi等人（2020）还指出，整合区块链和物联网可以提供不可伪造性和可追溯性的能力，从而有助于减少药品转移和盗窃的可能性。
- en: Application in the Packaging Process
  id: totrans-319
  prefs: []
  type: TYPE_NORMAL
  zh: 包装过程中的应用
- en: As opinion provided by Premkumar and C. (2020), the combination of IoT and blockchain
    could allow the manufacturers to realize and excel at digital twin initiatives
    that enable enterprises to monitor the whole lifecycle of products. Premkumar
    and C. (2020) described that IoT could support data monitoring and updating in
    real-time, while blockchain could record all information securely and immutably.
    There are some specific requirements for the packaging process when implementing
    IoT and blockchain. The studies conducted by Huang, Wu and Long (2018), Sylim
    et al.(2018), Chiacchio et al. (2019) and Pandey and Lotoriya (2020) presented
    the system design and special requirements, such as:.
  id: totrans-320
  prefs: []
  type: TYPE_NORMAL
  zh: Premkumar和C.（2020）提供的观点认为，物联网和区块链的结合可以让制造商实现和优化数字孪生项目，使企业能够监控产品的整个生命周期。Premkumar和C.（2020）描述了物联网可以支持实时数据监测和更新，而区块链可以安全、不可篡改地记录所有信息。在实施物联网和区块链时，包装过程存在一些特定要求。Huang、Wu和Long（2018）、Sylim等人（2018）、Chiacchio等人（2019）和Pandey和Lotoriya（2020）进行的研究提出了系统设计和特殊要求，例如：
- en: • RFID and Blockchain
  id: totrans-321
  prefs:
  - PREF_UL
  type: TYPE_NORMAL
  zh: '-   RFID和区块链'
- en: Barcode and RFID technology are adopted in a system called Drugledger designed
    by Huang, Wu and Long (2018). The author described that the RFID or barcode is
    encoded with raw data and it would be labelled on the packages of drugs. Only
    the certificated enterprise could join the Drugledger as a node, which could ensure
    the network security. The author highlighted the encoded hash of raw data would
    serve as metadata added into the system for querying the whole tracking and tracing
    information. Therefore, it requires participants in PSC to scan QR or RFID tags
    on the package to get the encoded hash when transactions happen. In particular,
    since the system considered different packaging levels and the situation of repackaging
    and unpacking. So, Drugledger blockchain could support recording transactions
    and movement of drugs with the different-level package.
  id: totrans-322
  prefs: []
  type: TYPE_NORMAL
  zh: 黄、吴和龙（2018）设计的Drugledger系统采用了条形码和RFID技术。作者描述了RFID或条形码编码了原始数据，并贴在药物包装上。只有获得证书的企业才能作为节点加入Drugledger，这可以确保网络安全。作者强调，原始数据的编码哈希将作为元数据添加到系统中，用于查询整个跟踪信息。因此，在PSC中，参与者需要在交易发生时扫描包装上的QR码或RFID标签以获取编码哈希。特别是，由于系统考虑了不同的包装级别以及重新包装和拆包的情况。因此，Drugledger区块链可以支持记录不同级别包装的药品交易和移动。
- en: • RFID, GTIN with Blockchain
  id: totrans-323
  prefs:
  - PREF_UL
  type: TYPE_NORMAL
  zh: '-   RFID、GTIN与区块链'
- en: In 2018, a drug surveillance system was developed by Sylim et al. (2018). To
    ensure the system could take effect, it requires a RFID and GTIN (global identifier
    number) following GS1 standard to be allocated to each physical drug unit and
    shipment package separately for creating the manufacturing and shipping pedigrees.
    Furthermore, the package contains the specific information such as hash code and
    the above two pedigrees. The authenticity of the drug could be verified by scanning
    the RFID, and then the verified transaction would be encrypted and entered into
    the network by participants of PSC. This process would continue from production
    to the final sale point. With entire data flow, end-users could scan the code
    to check the drug distribution history, confirming the drug provenance. Nevertheless,
    the main limitation of the presented system is invalid for tracking fake drug
    distribution outside the official PSC.
  id: totrans-324
  prefs: []
  type: TYPE_NORMAL
  zh: 2018 年，Sylim 等人开发了一种药品监测系统。为确保系统能够生效，需要根据 GS1 标准为每个实际药品单元和运输包分配 RFID 和 GTIN（全球标识号码），以创建生产和运输谱系。此外，包装中包含特定信息，如哈希代码和上述两个谱系。通过扫描
    RFID，可以验证药品的真实性，然后由 PSC 参与者加密并输入网络的验证交易。此过程将从生产一直持续到最终销售点。通过整个数据流，最终用户可以扫描代码以检查药品的分销历史，确认药品的来源。然而，所提出系统的主要限制是无法跟踪官方
    PSC 以外的假药分销。
- en: • QR Code and Blockchain
  id: totrans-325
  prefs:
  - PREF_UL
  type: TYPE_NORMAL
  zh: • 二维码和区块链
- en: Pandey and Lotoriya (2020) proposed a system-based QR code and blockchain. The
    package of each sales unit, sub-package and sale, whole-carton are printed with
    a unique QR code that contains key production information such as batch number,
    production date and expiry date, etc. The information of the drug could be obtained
    and checked easily with the help of various information identifier. Partners in
    PSC could verify drug authenticity via scanning QR code and then record verified
    information on the ledger. As the QR code has already registered at the beginning,
    counterfeit drugs could be detected by the system automatically through checking
    whether the products with the same ID has been recorded before. The integral information
    flow enables tracking drugs throughout the PSC, which could provide provenance
    evaluation. Also, the end-consumers could verify drug authenticity. However, this
    study only works in a limited geographical area, and could not ensure the effectiveness
    in other areas. Also, the system could only be effective for medicines that are
    authorized in the system.
  id: totrans-326
  prefs: []
  type: TYPE_NORMAL
  zh: Pandey 和 Lotoriya（2020）提出了一种基于二维码和区块链的系统。每个销售单元、子包装、销售、整箱都印有包含批号、生产日期、到期日期等关键生产信息的唯一二维码。在
    PSC 中，借助各种信息标识符，可以轻松获取和检查药品信息。PSC 中的合作伙伴可以通过扫描二维码验证药品的真实性，然后在分类帐上记录验证信息。由于二维码在开始时已经注册，系统可以通过检查是否已经记录了具有相同
    ID 的产品，自动检测到假冒药品。完整的信息流使得在 PSC 中跟踪药品成为可能，从而可以提供药品溯源评估。此外，最终消费者也可以验证药品的真实性。然而，该研究仅适用于有限的地理区域，并且不能确保在其他地区的有效性。此外，该系统只对在系统中获得授权的药品有效。
- en: • Serialisation and Blockchain
  id: totrans-327
  prefs:
  - PREF_UL
  type: TYPE_NORMAL
  zh: • 序列化和区块链
- en: The serialisation technology enables each level of the drug to have a unique
    serial number on its package, with the hierarchy matrix list generated by a serialisation
    software. This ensures that the product could be tracked (Chiacchio et al., 2019).
    The role and functions of the serial number is similar to the information identifiers
    such as QR code and RFID mentioned above. In order to combine the blockchain with
    the serialisation system, a BC server would have to be developed for realizing
    the information transmission that facilitates the storage of the hierarchy matrix
    in the blockchain. Moreover, the interaction of servers and smart contracts would
    generate a QR code as the unique electronic identity for each drug. Similarly,
    the QR code would be labelled on the package of the corresponding drug. The system
    enables the final client to verify the authenticity of the drug by scanning the
    QR code on the package. The effectiveness of the system would already be confirmed
    through testing. The authors found that the Ethereum has a little delay for generating
    QR code, which might decrease the production capacity in the packaging process.
    Therefore, there might be a need to investigate other blockchain platforms with
    lower latency and higher transaction (Chiacchio et al., 2020).
  id: totrans-328
  prefs: []
  type: TYPE_NORMAL
  zh: 序列化技术使得药品的每个层级都在其包装上拥有独特的序列号，由序列化软件生成层次矩阵列表。这确保了产品的可追踪性（Chiacchio等，2019）。序列号的作用和功能类似于上文提到的QR码和RFID等信息标识符。为了将区块链与序列化系统结合起来，需要为实现信息传输开发一个BC服务器，以便在区块链中存储层次矩阵。此外，服务器和智能合约的交互将生成QR码作为每种药品的唯一电子身份。类似地，QR码将标在相应药品的包装上。该系统使最终客户能够通过扫描包装上的QR码来验证药品的真实性。系统的有效性已经通过测试得到确认。作者发现以太坊生成QR码的速度稍有延迟，可能会降低包装过程中的生产能力。因此，可能需要调查其他具有较低延迟和更高交易性能的区块链平台（Chiacchio等，2020）。
- en: • Serial Number, Fingerprint and Blockchain
  id: totrans-329
  prefs:
  - PREF_UL
  type: TYPE_NORMAL
  zh: '**序列号**、**指纹**和**区块链**'
- en: A new information identifier named fingerprint was adopted in a model proposed
    by Sahoo et al. (2019). In particular, the fingerprint is hard to copy, and could
    ensure authenticity. Sahoo et al. (2019) described that all participants in the
    PSC are included in the network. A serial number and unique fingerprint of the
    drug’s manufacture would be attached to each package of sale unit. Meanwhile,
    the serial numbers of the inner products would be contained in the drug package
    at the transportation level. The verified transactions, information about serial
    number would be scanned and recorded on the blockchain in real-time by participants
    in the PSC, which made the footprints of the drug visible in the blockchain. Also,
    the model allowed end-users to review relative data by scanning the drug serial
    number through a cloud platform of blockchain.
  id: totrans-330
  prefs: []
  type: TYPE_NORMAL
  zh: Sahoo等人（2019）提出的模型采用了一种名为指纹的新信息标识符。特别是，指纹难以复制，并且能确保真实性。Sahoo等人（2019）描述了PSC中的所有参与者都包含在网络中。每个销售单位的包装上将附有药品制造的序列号和唯一指纹。同时，内部产品的序列号将包含在运输层次的药品包装中。验证的交易、序列号信息将由PSC的参与者实时扫描并记录在区块链上，使药品的足迹在区块链上可见。此外，该模型允许最终用户通过在区块链的云平台上扫描药品序列号来查看相关数据。
- en: Application in the Transportation Process
  id: totrans-331
  prefs: []
  type: TYPE_NORMAL
  zh: 运输过程中的应用
- en: There are some temperature-sensitive drugs, whose quality would be affected
    by the unsuitable environment. According to the GDP regulation, it requires recording
    of temperature during the distribution process to ensure consistent quality and
    any deviation must be reported (Papert, Rimpler and Pflaum, 2016a; Bocek et al.,
    2017). Several studies indicated the advantages of applying IoT and blockchain
    in real-time drug environment monitoring. Hastig and Sodhi (2020) adverted the
    IoT technology including RFID tags and sensors would help to monitor the temperature
    change in the end-to-end PSC. Besides, Sahoo et al.(2019) also suggested that
    attaching IoT sensors like wireless sensors or GPS to the drug package helps in
    environment and location monitoring. However, the number of studies related to
    IoT and blockchain application in transportation are limited.
  id: totrans-332
  prefs: []
  type: TYPE_NORMAL
  zh: 有一些对温度敏感的药物，其质量会受到不适宜的环境影响。根据 GDP 规定，需要在配送过程中记录温度，以确保一致的质量，并且任何偏差必须报告（Papert、Rimpler
    和 Pflaum，2016a；Bocek 等，2017年）。几项研究表明，在实时药品环境监测中应用物联网和区块链的优势。Hastig 和 Sodhi（2020年）提到，包括
    RFID 标签和传感器在内的物联网技术将有助于监测端到端的 PSC 中的温度变化。此外，Sahoo 等人（2019年）还建议将物联网传感器（如无线传感器或
    GPS）附加到药品包装上，以帮助进行环境和位置监测。然而，与运输相关的物联网和区块链应用的研究数量有限。
- en: A company named Modum.io. designed a system using IoT devices and Ethereum blockchain
    technology to assist in drug temperature monitoring, and therefore, guarantee
    regulatory compliance and effective quality control over the transportation process
    (Bocek et al., 2017). The compositions of the system are shown in Table 9.
  id: totrans-333
  prefs: []
  type: TYPE_NORMAL
  zh: Modum.io 公司设计了一个系统，利用物联网设备和以太坊区块链技术来辅助药品温度监测，从而保证监管合规性和有效的质量控制运输过程（Bocek 等，2017年）。该系统的组成如表9所示。
- en: Table 9\. Architectures of system designed by Modum.io. company
  id: totrans-334
  prefs: []
  type: TYPE_NORMAL
  zh: 表9。Modum.io 公司设计的系统架构
- en: '| Architecture | Components | Function |'
  id: totrans-335
  prefs: []
  type: TYPE_TB
  zh: '| 架构 | 组件 | 功能 |'
- en: '| IoT devices | Bluetooth sensors | provide temperature data |'
  id: totrans-336
  prefs: []
  type: TYPE_TB
  zh: '| 物联网设备 | 蓝牙传感器 | 提供温度数据 |'
- en: '| Database | n/a | Data and user credentials storage |'
  id: totrans-337
  prefs: []
  type: TYPE_TB
  zh: '| 数据库 | n/a | 数据和用户凭证存储 |'
- en: '| Smart contracts | n/a | Defining transactions to guarantee that the temperature
    during the entire transportation complies with regulation. |'
  id: totrans-338
  prefs: []
  type: TYPE_TB
  zh: '| 智能合约 | n/a | 定义交易以确保整个运输过程中的温度符合规定。 |'
- en: '| Server | n/a | Serve as interfaces and support communication between blockchain
    and front-end-user. |'
  id: totrans-339
  prefs: []
  type: TYPE_TB
  zh: '| 服务器 | n/a | 用作区块链和前端用户之间的接口并支持通信。 |'
- en: '| Mobile devices | n/a | Enable end-users to do operations such as new shipment
    registration and keeping track of temperature record. |'
  id: totrans-340
  prefs: []
  type: TYPE_TB
  zh: '| 移动设备 | n/a | 使终端用户能够执行操作，例如新货运注册和跟踪温度记录。 |'
- en: '| Ethereum blockchain network | n/a | Store intelligent smart contract code,
    Verify temperature data resisted in the front-end. |'
  id: totrans-341
  prefs: []
  type: TYPE_TB
  zh: '| 以太坊区块链网络 | n/a | 存储智能智能合约代码，验证前端存储的温度数据。 |'
- en: 'Source: (Bocek et al., 2017).'
  id: totrans-342
  prefs: []
  type: TYPE_NORMAL
  zh: 来源：（Bocek 等，2017年）。
- en: According to studies of Bocek et al. (2017), a tracking number would be attached
    to the drug package, and each sensor owns an address number. Sensor devices are
    placed at the appropriate point of the shipment. The temperature would be recorded
    by the sensor continuously and then stored in its database. The temperature data
    would be downloaded by scanning the tracking number on the drug package to connect
    the sensor, and then data could be sent to smart contracts. In this way, participants
    in the blockchain could verify the data. The approach could enhance regulatory
    compliance and guarantee quality control during transportation.
  id: totrans-343
  prefs: []
  type: TYPE_NORMAL
  zh: 根据 Bocek 等人的研究（2017年），药品包装上将附有一个跟踪号码，每个传感器都有一个地址号码。传感器设备放置在货物适当的点上。传感器将持续记录温度，然后将其存储在其数据库中。通过扫描药品包装上的跟踪号码来连接传感器，温度数据将被下载，然后数据可以发送到智能合约。通过这种方式，区块链中的参与者可以验证数据。这种方法可以增强运输过程中的监管合规性并保证质量控制。
- en: This study proved it is possible to adopt IoT and blockchain technology in the
    drug transportation process to record and monitor the environment change. With
    continuous monitoring, the drug quality could be better guaranteed. The architectures
    were designed by Modum.io. The company provided a rough idea and method of combining
    IoT and blockchain in the PSC. However, it only focused on temperature monitoring,
    which is limited. In future studies and practice, researchers or companies could
    choose the right IoT sensor and blockchain platform to develop other functions
    such as humidity, location and other information monitoring in the transportation
    process based on this architecture.
  id: totrans-344
  prefs: []
  type: TYPE_NORMAL
  zh: 这项研究证明了在药品运输过程中采用物联网和区块链技术记录和监控环境变化是可行的。通过持续监测，可以更好地保证药品质量。这些架构由Modum.io设计。该公司提供了将物联网和区块链结合到PSC中的大致想法和方法。然而，它只关注温度监测，这是有限的。在未来的研究和实践中，研究人员或公司可以根据这种架构选择合适的物联网传感器和区块链平台，开发其他功能，例如湿度、位置和其他信息的运输过程监控。
- en: Framework for Combining IoT and Blockchain in PSC
  id: totrans-345
  prefs: []
  type: TYPE_NORMAL
  zh: 在PSC中结合物联网和区块链的框架
- en: In light of the problems in the current PSC. An architectural design for the
    PSC management system has been proposed by Shi, Yi and Kuang (2019). The model
    is based on the blockchain and IoT techniques. It is composed of six modules.
    (1) IoT module, (2) Application module, (3) Certificate authority, (4) Transaction
    private module, (5) Smart contract module, (6) Fabric blockchain. Shi, Yi and
    Kuang (2019) indicated that the model could ensure that data is transparent, authentic,
    not tampered with, and traceable. The functional test results were satisfactory.
  id: totrans-346
  prefs: []
  type: TYPE_NORMAL
  zh: 鉴于当前PSC存在的问题。石、易和匡（2019）提出了PSC管理系统的架构设计。该模型基于区块链和物联网技术。它由六个模块组成。（1）物联网模块，（2）应用程序模块，（3）证书授权，（4）交易私有模块，（5）智能合约模块，（6）Fabric区块链。石、易和匡（2019）指出，该模型可以确保数据透明、真实、不被篡改和可追溯。功能测试结果令人满意。
- en: By combining the studies related to IoT and blockchain in PSC, authors summarized
    a basic framework for integrating IoT and blockchain in the PSC, which could give
    a detailed idea about how to combine two technologies in PSC for obtaining several
    advantages. The detailed system modules are described in table 10.
  id: totrans-347
  prefs: []
  type: TYPE_NORMAL
  zh: 通过结合与PSC相关的物联网和区块链研究，作者总结了一个基本的框架，用于在PSC中集成物联网和区块链，这可以详细说明如何在PSC中结合两种技术以获得多种优势。表10描述了详细的系统模块。
- en: Table 10\. Modules of PSC system
  id: totrans-348
  prefs: []
  type: TYPE_NORMAL
  zh: 表10\. PSC系统模块
- en: '| Module | Composition | Function |'
  id: totrans-349
  prefs: []
  type: TYPE_TB
  zh: '| 模块 | 组成 | 功能 |'
- en: '| IoT module | Data acquisition devices (GPS, Barcode, serial number, RFID,
    sensors and their networks) | Collect and upload data in real-time |'
  id: totrans-350
  prefs: []
  type: TYPE_TB
  zh: '| 物联网模块 | 数据采集设备（GPS、条形码、序列号、RFID、传感器及其网络） | 实时收集并上传数据 |'
- en: '| Application module | • Data uploaded sub-module, • Data query sub-module.
    | • Receive data, • Query data'
  id: totrans-351
  prefs: []
  type: TYPE_NORMAL
  zh: '| 应用程序模块 | • 数据上传子模块，• 数据查询子模块。 | • 接收数据，• 查询数据'
- en: • Transfer various data from IoT devices to privacy module.
  id: totrans-352
  prefs: []
  type: TYPE_NORMAL
  zh: • 将来自物联网设备的各种数据传输到隐私模块。
- en: • As interface, to support conmmunication between IoT devices and blockchain
    network
  id: totrans-353
  prefs: []
  type: TYPE_NORMAL
  zh: • 作为接口，支持物联网设备与区块链网络之间的通信
- en: • enable end users to do operations via mobile application |
  id: totrans-354
  prefs: []
  type: TYPE_NORMAL
  zh: • 通过移动应用程序使最终用户能够执行操作 |
- en: '| Database | n/a | Data and user credentials storage |'
  id: totrans-355
  prefs: []
  type: TYPE_TB
  zh: '| 数据库 | n/a | 数据和用户凭证存储 |'
- en: '| Certificate authority | n/a | • Generating public key and private key, •
    Provide version number for each member in the blockchain |'
  id: totrans-356
  prefs: []
  type: TYPE_TB
  zh: '| 证书授权 | n/a | • 生成公钥和私钥，• 为区块链中的每个成员提供版本号 |'
- en: '| Transaction private module | Key participants in the network (manufacturers,
    wholesalers, retailers, carriers etc.) | Data encryption and decryption, ensure
    privacy and security |'
  id: totrans-357
  prefs: []
  type: TYPE_TB
  zh: '| 交易私有模块 | 网络中的关键参与者（制造商、批发商、零售商、承运商等） | 数据加密和解密，确保隐私和安全 |'
- en: '| Smart contract module | n/a | • Provide AIP (Application Programming Interface)
    deploy, call, execute and logout contract. • Defining transactions to guarantee
    the temperature in whole transportation is regulatory compliance. |'
  id: totrans-358
  prefs: []
  type: TYPE_TB
  zh: '| 智能合约模块 | n/a | • 提供 AIP（应用程序接口）部署、调用、执行和注销合约。 • 定义交易以确保整个运输过程中的温度符合法规。 |'
- en: '| Blockchain platform | Ethereum platform or Hyperleger fabric platform | •
    Connect nodes of participants, • Store intelligent smart contract code,'
  id: totrans-359
  prefs: []
  type: TYPE_NORMAL
  zh: '| 区块链平台 | 以太坊平台或超级账本面料平台 | • 连接参与者节点，• 存储智能合约代码，'
- en: • Store or return data in blockchain. |
  id: totrans-360
  prefs: []
  type: TYPE_NORMAL
  zh: • 在区块链中存储或返回数据。
- en: 'Source: Shi, Yi and Kuang (2019) and (Bocek et al., 2017)'
  id: totrans-361
  prefs: []
  type: TYPE_NORMAL
  zh: 来源：石、易和匡（2019）和（Bocek等，2017）
- en: The drug company could choose diffident kinds of IoT devices and blockchain
    platforms based on the demand and its requirement. Besides IoT devices and blockchain
    platforms, other models could also help to establish a connection and realize
    functions for participants and users. Therefore, the company could view the above
    multiple models as a basic framework to develop their own PSC management system
    to integrate IoT and blockchain.
  id: totrans-362
  prefs: []
  type: TYPE_NORMAL
  zh: 药企可以根据需求和要求选择不同种类的IoT设备和区块链平台。除了IoT设备和区块链平台之外，其他模型也可以帮助建立连接并实现参与者和用户的功能。因此，公司可以将上述多种模型视为开发其自己的PSC管理系统的基本框架，以整合IoT和区块链。
- en: Challenge of IoT and Blockchain Application in PSC
  id: totrans-363
  prefs: []
  type: TYPE_NORMAL
  zh: PSC中的IoT和区块链应用挑战
- en: As the appearance of IoT and blockchain combination is not for a long time and
    it is clear that the pharmaceutical industry is highly regulated. Therefore, there
    are several challenges when applying the new integrated technology in the PSC.
  id: totrans-364
  prefs: []
  type: TYPE_NORMAL
  zh: 由于IoT和区块链组合的出现时间不长，而且明显制药行业受到高度监管。因此，在PSC中应用新的综合技术时存在几个挑战。
- en: 1\. Lacking regulations and policy
  id: totrans-365
  prefs:
  - PREF_UL
  type: TYPE_NORMAL
  zh: 1\. 缺乏规章制度和政策
- en: There are some risks to the privacy and surety of IoT. Although several studies
    confirmed that IoT and blockchain applications could bring great advantages to
    PSC. With the sustained growth of IoT-based data sharing, a lack of regulation
    to enhance the governance of data sharing based on IoT might lead to high risks
    in security and privacy (Srivastava et al., 2019). Secondly, there are no policies
    to incentivize technology implementation (Sylim et al., 2018a).
  id: totrans-366
  prefs: []
  type: TYPE_NORMAL
  zh: IoT的隐私和可靠性存在一些风险。虽然几项研究证实了IoT和区块链应用可能带来PSC的巨大优势。随着基于IoT的数据共享持续增长，缺乏规范以增强基于IoT的数据共享治理可能导致安全和隐私方面的高风险（Srivastava等人，2019年）。其次，没有政策鼓励技术实施（Sylim等人，2018a）。
- en: 2\. Acceptance
  id: totrans-367
  prefs:
  - PREF_UL
  type: TYPE_NORMAL
  zh: 2\. 接受
- en: The superiority of IoT and blockchain application in PSC could only be achieved
    when all companies involved in the PSC are willing to participate in the network.
    So, making the blockchain accepted by the pharmaceutical industry and to promote
    the application is a challenging task (Huang, Wu and Long 2018; Srivastava et
    al., 2019).
  id: totrans-368
  prefs: []
  type: TYPE_NORMAL
  zh: 只有PSC中涉及的所有公司都愿意参与网络，IoT和区块链应用在PSC中的优势才能实现。因此，使区块链被制药行业接受并推广其应用是一项具有挑战性的任务（Huang，Wu和Long
    2018年；Srivastava等人，2019年）。
- en: 3\. Writing of smart contracts
  id: totrans-369
  prefs:
  - PREF_UL
  type: TYPE_NORMAL
  zh: 3\. 智能合约的编写
- en: Smart contracts are the most advantageous application that could bring huge
    benefits to the supply chain. However, writing smart contracts faces some challenges.
    Firstly, the programming language of smart contracts is new, and it is hard to
    maintain. Secondly, the efficiency of transaction execution is low, reason being
    all transactions are executed amongst all the nodes (Sylim et al., 2018; Abbas
    et al., 2020).
  id: totrans-370
  prefs: []
  type: TYPE_NORMAL
  zh: 智能合约是能为供应链带来巨大利益的最有利的应用。然而，编写智能合约面临一些挑战。首先，智能合约的编程语言是新的，很难维护。其次，交易执行效率低，原因是所有交易都在所有节点之间执行（Sylim等人，2018年；Abbas等人，2020年）。
- en: 4\. Efficiency of blockchain
  id: totrans-371
  prefs:
  - PREF_UL
  type: TYPE_NORMAL
  zh: 4\. 区块链的效率
- en: With the increase in number of nodes and transactions in the network, more verification
    is required for the transaction to be executed. As a result the throughput of
    blockchain would negatively affect the efficiency of PSC (Zhou et al., 2019).
  id: totrans-372
  prefs: []
  type: TYPE_NORMAL
  zh: 随着网络中节点和交易数量的增加，需要更多的验证才能执行交易。因此，区块链的吞吐量会对PSC的效率产生负面影响（Zhou等人，2019年）。
- en: 5\. Other barriers
  id: totrans-373
  prefs:
  - PREF_UL
  type: TYPE_NORMAL
  zh: 5\. 其他障碍
- en: Radanović and Likić (2018) suggested that blockchain technology is still immature
    and public or expert knowledge is insufficient.
  id: totrans-374
  prefs: []
  type: TYPE_NORMAL
  zh: Radanović和Likić（2018）认为区块链技术仍不成熟，公众或专家知识不足。
- en: CONCLUSION
  id: totrans-375
  prefs: []
  type: TYPE_NORMAL
  zh: 结论
- en: Review of Objectives
  id: totrans-376
  prefs: []
  type: TYPE_NORMAL
  zh: 目标回顾
- en: The authors consider that all the objectives set out in this chapter have been
    achieved.
  id: totrans-377
  prefs: []
  type: TYPE_NORMAL
  zh: 作者认为本章提出的所有目标都已经实现。
- en: 'Objective 1: The literature was summarized with relative information related
    to main challenges or issues in PSC. Three main challenges that are faced by PSC
    are poor traceability, low transparency, and lack of authenticity. Some of the
    problems as discussed in the review of complex PSC environment are different practices
    of enterprises, insufficient information management systems, unsatisfactory track
    and trace system, etc.'
  id: totrans-378
  prefs: []
  type: TYPE_NORMAL
  zh: 目标1：文献概括了与PSC主要挑战或问题相关的相关信息。 PSC面临的三个主要挑战是追溯性差、透明度低和真实性缺乏。如在复杂PSC环境的审查中讨论的一些问题是企业的不同实践、信息管理系统不足、跟踪系统不尽人意等。
- en: 'Objective 2: Descriptive analysis was conducted for the opportunities and issues
    that IoT and blockchain application have on the aspect of information management
    and provenance in PSC. There is a short description of the existing IoT devices
    applied in PSC and the proposed blockchain system in this chapter. The publications
    on IoT and blockchain applications in current PSC showed potential opportunities.
    Nevertheless, most of the blockchain systems proposed by researchers lacked system
    effectiveness. The challenges discussed in the review include the aspects of regulation,
    expertise, as well as the acceptance of the pharmaceutical industry. All of these
    challenges would influence the effectiveness of implementing IoT and blockchain
    in the PSC.'
  id: totrans-379
  prefs: []
  type: TYPE_NORMAL
  zh: '目标 2: 对物联网和区块链应用在 PSC 中信息管理和来源方面的机会和问题进行了描述性分析。本章对在 PSC 中应用的现有物联网设备和拟议的区块链系统进行了简要描述。目前
    PSC 中的物联网和区块链应用的出版物显示出潜在的机会。然而，研究人员提出的大多数区块链系统缺乏系统效力。审查中讨论的挑战包括监管、专业知识以及制药行业的接受程度等方面。所有这些挑战都将影响在
    PSC 中实施物联网和区块链的效果。'
- en: 'Objective 3: An effort was made to achieve this objective by dividing it into
    2 parts which is the combination of IoT and Blockchain application in PSC and
    the suggested framework for integrating IoT and blockchain in PSC. Although developing
    blockchain for PSC management is still at the initial phase, multiple pieces of
    research have already demonstrated that the application of IoT and blockchain
    in PSC could provide a secure, authentic, reliable, trustworthy, immutable, traceable
    as well as tamper proof environment to support the PSC. That application could
    facilitate the collection of drug information, record and share information and
    transactions with involved participants in PSC. With the integral and reliable
    information flow, the transparency, traceability and authenticity of PSC could
    be improved effectively. Hence, problems such as counterfeit drugs and low trust
    relationships amongst partners of PSC could be resolved. For the IoT and blockchain
    integration, this chapter focused on the packaging process and transportation
    process. More importantly, this chapter provides a rough basic framework of IoT
    and blockchain combination structure in PSC based on the review of existing studies,
    which presents the essential models when combining IoT and blockchain.'
  id: totrans-380
  prefs: []
  type: TYPE_NORMAL
  zh: '目标 3: 通过将其分为物联网和区块链应用在 PSC 中的组合以及在 PSC 中集成物联网和区块链的建议框架的两个部分来实现此目标的努力。虽然开发 PSC
    管理的区块链仍处于初期阶段，但已有多项研究表明，在 PSC 中应用物联网和区块链可以提供安全、真实、可靠、可信、不可变、可追踪以及防篡改的环境来支持 PSC。该应用可以促进药品信息的收集，记录并与参与
    PSC 的相关参与者共享信息和交易。借助完整可靠的信息流动，PSC 的透明度、可追踪性和真实性可以得到有效改善。因此，诸如假药和 PSC 合作伙伴之间信任度低等问题可以得到解决。对于物联网和区块链的集成，本章重点关注包装过程和运输过程。更重要的是，本章基于对现有研究的审查提供了物联网和区块链在
    PSC 中组合结构的初步基本框架，提出了结合物联网和区块链时的关键模型。'
- en: The Limitations and Future Research
  id: totrans-381
  prefs: []
  type: TYPE_NORMAL
  zh: 限制和未来研究
- en: The findings of this study must be seen in the light of following limitations.
    Firstly, the sample size and the number of academic literatures used for the review.
    As blockchain and IoT integration technology are still in the initial phase, there
    is limited research done on this topic. Therefore, the number of selected academic
    peer-reviewed journals, journal papers and conference papers are unbalanced. Furthermore,
    the ranking of most selected scholarly papers is unspecific. Secondly, there were
    only few articles related to the implementation of IoT and blockchain in the drug
    transportation process, which might be because IoT and blockchain application
    is still in the initial phase. Finally, the framework provided in this chapter
    is by combining IoT and Blockchain in PSC. It is composed of six modules. (1)
    IoT module, (2) Application module, (3) Certificate authority, (4) Transaction
    private module, (5) Smart contract module, and (6) Fabric blockchain. Further
    research should be conducted to simulate the framework, enabling a stepped approach
    towards best practice.
  id: totrans-382
  prefs: []
  type: TYPE_NORMAL
  zh: 这项研究的发现必须从以下几个限制条件中看待。首先是样本量和用于审查的学术文献数量。由于区块链和物联网集成技术仍处于初级阶段，因此对这个主题的研究有限。因此，选定的学术同行评议期刊、期刊论文和会议论文的数量不平衡。此外，大多数选定的学术论文的排名不明确。其次，与药品运输过程中物联网和区块链的实施相关的文章很少，这可能是因为物联网和区块链应用仍处于初级阶段。最后，本章提供的框架是通过将物联网和区块链结合在
    PSC 中而形成的。它由六个模块组成。(1) 物联网模块，(2) 应用程序模块，(3) 证书授权，(4) 交易私有模块，(5) 智能合约模块，以及 (6)
    Fabric 区块链。应进一步进行研究以模拟框架，实现朝着最佳实践的阶段性方法。
- en: REFERENCES
  id: totrans-383
  prefs: []
  type: TYPE_NORMAL
  zh: 参考文献
- en: Abbas, K., Afaq, M., Khan, T. A., & Song, W.-C. (2020). A blockchain and machine
    learning-based drug supply chain management and recommendation system for smart
    pharmaceutical industry . Electronics (Switzerland) , 9(5), 852.
  id: totrans-384
  prefs: []
  type: TYPE_NORMAL
  zh: Abbas, K., Afaq, M., Khan, T. A., & Song, W.-C. (2020). 基于区块链和机器学习的智能制药工业药品供应链管理和推荐系统。《电子学报》,
    9(5), 852.
- en: 'AhmadiV.BenjellounS.El KikM.SharmaT.ChiH.ZhouW. (2020). Drug Governance: IoT-based
    Blockchain Implementation in the Pharmaceutical Supply Chain. 6th International
    Conference on Mobile and Secure Services, MOBISECSERV 2020, 1–8\. 10.1109/MobiSecServ48690.2020.9042950'
  id: totrans-385
  prefs: []
  type: TYPE_NORMAL
  zh: AhmadiV.BenjellounS.El KikM.SharmaT.ChiH.ZhouW. (2020). 药品治理：物联网基于区块链的药品供应链实施。第六届移动与安全服务国际会议，MOBISECSERV
    2020，1–8。10.1109/MobiSecServ48690.2020.9042950
- en: 'AlangotB.AchuthanK. (2017, August). Trace and track: Enhanced pharma supply
    chain infrastructure to prevent fraud. In International Conference on Ubiquitous
    Communications and Network Computing (pp. 189-195). Springer.'
  id: totrans-386
  prefs: []
  type: TYPE_NORMAL
  zh: AlangotB.AchuthanK. (2017, 八月). 追溯和跟踪：增强的药品供应链基础设施以防止欺诈。《普及通信和网络计算国际会议》(pp.
    189-195)。Springer。
- en: Anand, R., Niyas, K., Gupta, S., & Revathy, S. (2020). Anti-counterfeit on medicine
    detection using blockchain technology . Lecture Notes in Networks and Systems
    , 89, 1223–1232\. doi:10.1007/978-981-15-0146-3_119
  id: totrans-387
  prefs: []
  type: TYPE_NORMAL
  zh: Anand, R., Niyas, K., Gupta, S., & Revathy, S. (2020). 利用区块链技术进行药品防伪检测。《网络与系统讲义》，89,
    1223–1232。doi:10.1007/978-981-15-0146-3_119
- en: Anon. (2018). 2018 Major Pharma Packaging Trends. In Pharmaceutical Processing.
    Advantage Business Media.
  id: totrans-388
  prefs: []
  type: TYPE_NORMAL
  zh: Anon. (2018). 2018 主要制药包装趋势。《制药加工》。Advantage Business Media.
- en: 'Arksey, H., & O’Malley, L. (2005). Scoping studies: Towards a methodological
    framework . International Journal of Social Research Methodology: Theory and Practice
    , 8(1), 19–32\. doi:10.1080/1364557032000119616'
  id: totrans-389
  prefs: []
  type: TYPE_NORMAL
  zh: Arksey, H., & O’Malley, L. (2005). 范围研究：朝着一个方法论框架。《社会研究方法学国际杂志：理论与实践》, 8(1),
    19–32。doi:10.1080/1364557032000119616
- en: 'ArmitageA.Keeble-allenD. (2008). Undertaking a Structured Literature Review
    or Structuring a Literature Review: Tales from the... by Academic Conferences
    and publishing International – Issuu. 7th European Conference on …, 6(2), 103–114.'
  id: totrans-390
  prefs: []
  type: TYPE_NORMAL
  zh: ArmitageA.Keeble-allenD. (2008). 进行结构化文献综述或构建文献综述：来自学术会议和出版国际的故事 – Issuu. 第七届欧洲会议，6(2),
    103–114。
- en: Barchetti, U., Bucciero, A., De Blasi, M., Guido, A. L., Mainetti, L., & Patrono,
    L. (2010). Impact of RFID, EPC and B2B on traceability management of the pharmaceutical
    supply chain. Proceeding - 5th International Conference on Computer Sciences and
    Convergence Information Technology, ICCIT 2010, 58–63\. 10.1109/ICCIT.2010.5711029
  id: totrans-391
  prefs: []
  type: TYPE_NORMAL
  zh: Barchetti, U., Bucciero, A., De Blasi, M., Guido, A. L., Mainetti, L., & Patrono,
    L. (2010). RFID、EPC 和 B2B 对药品供应链追溯管理的影响。第五届国际计算机科学与融合信息技术会议论文集，ICCIT 2010，58–63。10.1109/ICCIT.2010.5711029
- en: 'Ben-Daya, M., Hassini, E., & Bahroun, Z. (2019). Internet of things and supply
    chain management: A literature review . International Journal of Production Research
    , 57(15–16), 4719–4742\. doi:10.1080/00207543.2017.1402140'
  id: totrans-392
  prefs: []
  type: TYPE_NORMAL
  zh: Ben-Daya, M., Hassini, E., & Bahroun, Z. (2019). 物联网与供应链管理：一篇文献综述。生产研究国际期刊，57(15–16)，4719–4742。doi:10.1080/00207543.2017.1402140
- en: Benatia, M. A., De Sa, V. E., Baudry, D., Delalin, H., & Halftermeyer, P. (2018,
    March). A framework for big data driven product traceability system. In 2018 4th
    international conference on advanced technologies for signal and image processing
    (ATSIP) (pp. 1-7). IEEE. 10.1109/ATSIP.2018.8364340
  id: totrans-393
  prefs: []
  type: TYPE_NORMAL
  zh: Benatia, M. A., De Sa, V. E., Baudry, D., Delalin, H., & Halftermeyer, P. (2018年3月)。大数据驱动产品追溯系统的框架。2018年第4届高级技术信号与图像处理国际会议(ATSIP)，(pp.
    1-7)。IEEE。10.1109/ATSIP.2018.8364340
- en: BocekT.RodriguesB. B.StrasserT.StillerB. (2017). Blockchains everywhere - A
    use-case of blockchains in the pharma supply-chain. Proceedings of the IM 2017
    - 2017 IFIP/IEEE International Symposium on Integrated Network and Service Management,
    772–777\. 10.23919/INM.2017.7987376
  id: totrans-394
  prefs: []
  type: TYPE_NORMAL
  zh: BocekT.RodriguesB. B.StrasserT.StillerB. (2017). 到处都有的区块链 - 利用区块链技术的医药供应链用例。IM
    2017年会议论文集 - 2017 IFIP/IEEE国际集成网络与服务管理研讨会，772–777。10.23919/INM.2017.7987376
- en: BotchaK. M.ChakravarthyV. V. (2019, June). Enhancing traceability in pharmaceutical
    supply chain using Internet of Things (IoT) and blockchain. In 2019 IEEE International
    Conference on Intelligent Systems and Green Technology (ICISGT) (pp. 45-453).
    IEEE. 10.1109/ICISGT44072.2019.00025
  id: totrans-395
  prefs: []
  type: TYPE_NORMAL
  zh: BotchaK. M.ChakravarthyV. V. (2019年6月)。利用物联网(IoT)和区块链增强制药供应链的可追溯性。2019年IEEE智能系统与绿色技术国际会议(ICISGT)，(pp.
    45-453)。IEEE。10.1109/ICISGT44072.2019.00025
- en: 'BryatovS. R.BorodinovA. (2019, May). Blockchain technology in the pharmaceutical
    supply chain: Researching a business model based on Hyperledger Fabric. In Proceedings
    of the International Conference on Information Technology and Nanotechnology (ITNT)
    (pp. 21-24). 10.18287/1613-0073-2019-2416-134-140'
  id: totrans-396
  prefs: []
  type: TYPE_NORMAL
  zh: BryatovS. R.BorodinovA. (2019年5月)。制药供应链中的区块链技术：基于Hyperledger Fabric的商业模式研究。国际信息技术与纳米技术会议论文集(ITNT)，(pp.
    21-24)。10.18287/1613-0073-2019-2416-134-140
- en: 'Chanson, M., Bogner, A., Bilgeri, D., Fleisch, E., & Wortmann, F. (2019). Blockchain
    for the IoT: Privacy-preserving protection of sensor data . Journal of the Association
    for Information Systems , 20(9), 1271–1307\. doi:10.17705/1jais.00567'
  id: totrans-397
  prefs: []
  type: TYPE_NORMAL
  zh: Chanson, M., Bogner, A., Bilgeri, D., Fleisch, E., & Wortmann, F. (2019). 区块链与物联网：传感器数据的隐私保护。信息系统协会期刊，20(9)，1271–1307。doi:10.17705/1jais.00567
- en: Chiacchio, F., Compagno, L., D’Urso, D., Velardita, L., & Sandner, P. (2020).
    A decentralized application for the traceability process in the pharma industry.
    Procedia Manufacturing, 42, 362–369.
  id: totrans-398
  prefs: []
  type: TYPE_NORMAL
  zh: Chiacchio, F., Compagno, L., D’Urso, D., Velardita, L., & Sandner, P. (2020).
    制药行业追溯流程的去中心化应用。制造工程论文集，42，362–369。
- en: Chitre, M., Sapkal, S., Adhikari, A., & Mulla, S. (2019). Monitoring counterfeit
    drugs using counterchain. 2019 6th IEEE International Conference on Advances in
    Computing, Communication and Control, ICAC3 2019. 10.1109/ICAC347590.2019.9036794
  id: totrans-399
  prefs: []
  type: TYPE_NORMAL
  zh: Chitre, M., Sapkal, S., Adhikari, A., & Mulla, S. (2019)。使用反链监测假药。2019年第6届IEEE计算、通信和控制进展国际会议(ICAC3
    2019)。10.1109/ICAC347590.2019.9036794
- en: 'Clauson, K. A., Breeden, E. A., Davidson, C., & Mackey, T. K. (2018). Leveraging
    Blockchain Technology to Enhance Supply Chain Management in Healthcare: An Exploration
    of Challenges and Opportunities in the Health Supply Chain . Blockchain in Healthcare
    Today , 1(0), 1–12.'
  id: totrans-400
  prefs: []
  type: TYPE_NORMAL
  zh: Clauson, K. A., Breeden, E. A., Davidson, C., & Mackey, T. K. (2018). 利用区块链技术增强医疗保健供应链管理：探讨卫生供应链的挑战和机遇。医疗保健中的区块链，1(0)，1–12。
- en: 'Da Xu, L., He, W., & Li, S. (2014). Internet of things in industries: A survey
    . IEEE Transactions on Industrial Informatics , 10(4), 2233–2243\. doi:10.1109/TII.2014.2300753'
  id: totrans-401
  prefs: []
  type: TYPE_NORMAL
  zh: Da Xu, L., He, W., & Li, S. (2014). 工业物联网：一项调查。IEEE工业信息学交易，10(4)，2233–2243。doi:10.1109/TII.2014.2300753
- en: De Aguiar, E. J., Faiçal, B. S., Krishnamachari, B., & Ueyama, J. (2020). A
    Survey of Blockchain-Based Strategies for Healthcare . ACM Computing Surveys ,
    53(2), 1–27\. doi:10.1145/3376915
  id: totrans-402
  prefs: []
  type: TYPE_NORMAL
  zh: De Aguiar, E. J., Faiçal, B. S., Krishnamachari, B., & Ueyama, J. (2020). 医疗保健的基于区块链的策略调查。ACM计算调查，53(2)，1–27。doi:10.1145/3376915
- en: Dwivedi, S.K., Amin, R., & Vollala, S. (2020b). Blockchain based secured information
    sharing protocol in supply chain management system with key distribution mechanism.
    Journal of Information Security and Applications, 54.
  id: totrans-403
  prefs: []
  type: TYPE_NORMAL
  zh: Dwivedi, S.K., Amin, R., & Vollala, S. (2020b)。基于区块链的供应链管理系统中安全信息共享协议与密钥分发机制。信息安全与应用期刊，54。
- en: Hasan, H., AlHadhrami, E., AlDhaheri, A., Salah, K., & Jayaraman, R. (2019).
    Smart contract-based approach for efficient shipment management. Computers and
    Industrial Engineering, 136(July), 149–159.
  id: totrans-404
  prefs: []
  type: TYPE_NORMAL
  zh: Hasan, H., AlHadhrami, E., AlDhaheri, A., Salah, K., & Jayaraman, R. (2019).
    基于智能合约的高效货运管理方法。《计算机与工业工程》，136（7月），149–159。
- en: 'Hastig, G. M., & Sodhi, M. S. (2020). Blockchain for Supply Chain Traceability:
    Business Requirements and Critical Success Factors . Production and Operations
    Management , 29(4), 935–954\. doi:10.1111/poms.13147'
  id: totrans-405
  prefs: []
  type: TYPE_NORMAL
  zh: Hastig, G. M., & Sodhi, M. S. (2020). 区块链用于供应链追溯性：业务需求和关键成功因素。《生产与运营管理》，29（4），935–954。doi：10.1111/poms.13147
- en: Haughwout, J. (2018). Tracking medicine by transparent blockchain . Pharmaceutical
    Processing , 33(1), 24–26.
  id: totrans-406
  prefs: []
  type: TYPE_NORMAL
  zh: Haughwout, J. (2018). 透明区块链跟踪药品。《制药加工》，33（1），24–26。
- en: 'Huang, Y., Wu, J., & Long, C. (2018). Drugledger: A practical blockchain system
    for drug traceability and regulation. Proceedings - IEEE 2018 International Congress
    on Cybermatics: 2018 IEEE Conferences on Internet of Things, Green Computing and
    Communications, Cyber, Physical and Social Computing, Smart Data, Blockchain,
    Computer and Information Technology, iThings/Gree., 1137–1144\. 10.1109/Cybermatics_2018.2018.00206'
  id: totrans-407
  prefs: []
  type: TYPE_NORMAL
  zh: 黄远，吴晶，龙超（2018）。Drugledger：一种用于药品追溯和监管的实用区块链系统。IEEE 2018国际智能物联网大会论文集：2018 IEEE物联网、绿色计算与通信、网络安全、物理和社会计算、智能数据、区块链、计算机和信息技术会议，1137–1144。doi：10.1109/Cybermatics_2018.2018.00206
- en: 'Hyperledger. (2019). Case Study: How Walmart brought unprecedented transparency
    to the food supply chain with Hyperledger Fabric Challenge. Author.'
  id: totrans-408
  prefs: []
  type: TYPE_NORMAL
  zh: Hyperledger. (2019). 案例研究：沃尔玛如何通过Hyperledger Fabric挑战为食品供应链带来前所未有的透明度。作者。
- en: Jamil, F., Hang, L., Kim, K., & Kim, D. (2019). A novel medical blockchain model
    for drug supply chain integrity management in a smart hospital. Electronics, 8(5).
    doi:10.3390/electronics8050505
  id: totrans-409
  prefs: []
  type: TYPE_NORMAL
  zh: Jamil, F., Hang, L., Kim, K., & Kim, D. (2019). 医疗区块链模型用于智能医院中药品供应链完整性管理的新方法。《电子学》，8（5）。doi：10.3390/electronics8050505
- en: Jangir, S., Muzumdar, A., Jaiswal, A., Modi, C. N., Chandel, S., & Vyjayanthi,
    C. (2019). A Novel Framework for Pharmaceutical Supply Chain Management using
    Distributed Ledger and Smart Contracts. 2019 10th International Conference on
    Computing, Communication and Networking Technologies, ICCCNT 2019. 10.1109/ICCCNT45670.2019.8944829
  id: totrans-410
  prefs: []
  type: TYPE_NORMAL
  zh: Jangir, S., Muzumdar, A., Jaiswal, A., Modi, C. N., Chandel, S., & Vyjayanthi,
    C. (2019). 利用分布式账本和智能合约的制药供应链管理的新框架。2019年第十届计算、通信和网络技术国际会议，ICCCNT 2019。doi：10.1109/ICCCNT45670.2019.8944829
- en: 'Jha, S., Kumar, R., Chatterjee, J. M., & Khari, M. (2019). Collaborative handshaking
    approaches between internet of computing and internet of things towards a smart
    world: A review from 2009–2017 . Telecommunication Systems , 70(4), 617–634\.
    doi:10.1007/s11235-018-0481-x'
  id: totrans-411
  prefs: []
  type: TYPE_NORMAL
  zh: Jha, S., Kumar, R., Chatterjee, J. M., & Khari, M. (2019). 2009–2017年间物联网和计算机联网之间的协作握手方法综述。《电信系统》，70（4），617–634。doi：10.1007/s11235-018-0481-x
- en: Kamble, S.S., Gunasekaran, A., & Sharma, R. (2020). Modeling the blockchain
    enabled traceability in agriculture supply chain. International Journal of Information
    Management, 52(June).
  id: totrans-412
  prefs: []
  type: TYPE_NORMAL
  zh: Kamble, S.S., Gunasekaran, A., & Sharma, R. (2020). 在农业供应链中建模区块链启用的可追溯性。《国际信息管理期刊》，52（6月）。
- en: Khari, M., Garg, A. K., Gandomi, A. H., Gupta, R., Patan, R., & Balusamy, B.
    (2019). Securing data in Internet of Things (IoT) using cryptography and steganography
    techniques . IEEE Transactions on Systems, Man, and Cybernetics. Systems , 50(1),
    73–80\. doi:10.1109/TSMC.2019.2903785
  id: totrans-413
  prefs: []
  type: TYPE_NORMAL
  zh: Khari, M., Garg, A. K., Gandomi, A. H., Gupta, R., Patan, R., & Balusamy, B.
    (2019). 利用密码学和隐写术技术保护物联网中的数据。《IEEE系统、人类和网络。系统》，50（1），73–80。doi：10.1109/TSMC.2019.2903785
- en: Kim, H. M., & Laskowski, M. (2018b). Toward an ontology-driven blockchain design
    for supply-chain provenance . Intelligent Systems in Accounting, Finance & Management
    , 25(1), 18–27\. doi:10.1002/isaf.1424
  id: totrans-414
  prefs: []
  type: TYPE_NORMAL
  zh: Kim, H. M., & Laskowski, M. (2018b). 为供应链溯源设计的本体驱动区块链。《会计、金融与管理智能系统》，25（1），18–27。doi：10.1002/isaf.1424
- en: Kshetri, N. (2018). 1 Blockchain’s roles in meeting key supply chain management
    objectives. International Journal of Information Management, 39(June), 80–89\.
    .10.1016/j.ijinfomgt.2017.12.005
  id: totrans-415
  prefs: []
  type: TYPE_NORMAL
  zh: Kshetri, N. (2018). 区块链在实现关键供应链管理目标中的作用。《国际信息管理期刊》，39（6月），80–89。doi：10.1016/j.ijinfomgt.2017.12.005
- en: 'KumarA.ChoudharyD.RajuM. S.ChaudharyD. K.SagarR. K. (2019). Combating counterfeit
    drugs: A quantitative analysis on cracking down the fake drug industry by using
    blockchain technology. Proceedings of the 9th International Conference On Cloud
    Computing, Data Science and Engineering, Confluence 2019., 174–178\. 10.1109/CONFLUENCE.2019.8776891'
  id: totrans-416
  prefs: []
  type: TYPE_NORMAL
  zh: KumarA.ChoudharyD.RajuM. S.ChaudharyD. K.SagarR. K. (2019). 打击假药：使用区块链技术对打击假药行业进行定量分析。第9届云计算、数据科学和工程国际会议论文集，Confluence
    2019，174–178。10.1109/CONFLUENCE.2019.8776891
- en: Kumar, R., & Tripathi, R. (2019). Traceability of counterfeit medicine supply
    chain through Blockchain. 2019 11th International Conference on Communication
    Systems and Networks, COMSNETS 2019, 568–570\. 10.1109/COMSNETS.2019.8711418
  id: totrans-417
  prefs: []
  type: TYPE_NORMAL
  zh: Kumar, R., & Tripathi, R. (2019). 通过区块链追溯假药供应链。2019年第11届通信系统和网络国际会议，COMSNETS
    2019, 568–570。10.1109/COMSNETS.2019.8711418
- en: 'Kumari, K., & Saini, K. (2020). Data handling & drug traceability: Blockchain
    meets healthcare to combat counterfeit drugs . International Journal of Scientific
    and Technology Research , 9(3), 728–731.'
  id: totrans-418
  prefs: []
  type: TYPE_NORMAL
  zh: Kumari, K., & Saini, K. (2020). 数据处理与药品追溯：区块链与医疗保健结合打击假药。《科技研究国际期刊》，9(3), 728–731。
- en: Marbury, D. (2019). How Blockchain Can Reduce Waste, Fraud in Pharmacy. Drug
    Topics , 163(1), 30–31.
  id: totrans-419
  prefs: []
  type: TYPE_NORMAL
  zh: Marbury, D. (2019). 区块链如何减少药房浪费和欺诈。《药品话题》，163(1), 30–31。
- en: Markarian, J. (2018). Modernizing Pharma Manufacturing. Pharmaceutical Technology,
    42(4), 20–25.
  id: totrans-420
  prefs: []
  type: TYPE_NORMAL
  zh: Markarian, J. (2018). 现代化制药制造。《制药技术》，42(4), 20–25。
- en: 'Meyliana & Surjandy. (2019). Success factor of implementation blockchain technology
    in pharmaceutical industry: A literature review. 2019 6th International Conference
    on Information Technology, Computer and Electrical Engineering, ICITACEE 2019.'
  id: totrans-421
  prefs: []
  type: TYPE_NORMAL
  zh: Meyliana & Surjandy. (2019). 医药行业区块链技术实施成功因素：文献综述。2019年第6届国际信息技术、计算机和电气工程大会，ICITACEE
    2019。
- en: Molina, J. C., Delgado, D. T., & Tarazona, G. (2019). Using blockchain for traceability
    in the drug supply chain . Communications in Computer and Information Science
    , 1027, 536–548\. doi:10.1007/978-3-030-21451-7_46
  id: totrans-422
  prefs: []
  type: TYPE_NORMAL
  zh: Molina, J. C., Delgado, D. T., & Tarazona, G. (2019). 使用区块链追溯药品供应链。《计算机与信息科学通信》，1027,
    536–548。doi:10.1007/978-3-030-21451-7_46
- en: 'Musamih, A., Salah, K., Jayaraman, R., Arshad, J., Debe, M., Al-Hammadi, Y.,
    & Ellahham, S. (2021). A Blockchain-Based Approach for Drug Traceability in Healthcare
    Supply Chain . IEEE Access: Practical Innovations, Open Solutions , 9, 9728–9743\.
    doi:10.1109/ACCESS.2021.3049920'
  id: totrans-423
  prefs: []
  type: TYPE_NORMAL
  zh: 'Musamih, A., Salah, K., Jayaraman, R., Arshad, J., Debe, M., Al-Hammadi, Y.,
    & Ellahham, S. (2021). 医疗保健供应链中药品追溯的基于区块链的方法。《IEEE Access: 实用创新、开放解决方案》，9, 9728–9743。doi:10.1109/ACCESS.2021.3049920'
- en: Okoli, C. (2015). A Guide to Conducting a Standalone Systematic Literature Review
    . Communications of the Association for Information Systems , 37(1), 879–910\.
    doi:10.17705/1CAIS.03743
  id: totrans-424
  prefs: []
  type: TYPE_NORMAL
  zh: Okoli, C. (2015). 进行独立系统性文献综述的指南。《信息系统协会通讯》，37(1), 879–910。doi:10.17705/1CAIS.03743
- en: Olson-Hazboun, S. K., Howe, P. D., & Leiserowitz, A. (2018). ‘The influence
    of extractive activities on public support for renewable energy policy’. Energy
    Policy , 123, 117–126\. doi:10.1016/j.enpol.2018.08.044
  id: totrans-425
  prefs: []
  type: TYPE_NORMAL
  zh: Olson-Hazboun, S. K., Howe, P. D., & Leiserowitz, A. (2018). ‘开采活动对可再生能源政策公众支持的影响’。《能源政策》，123,
    117–126。doi:10.1016/j.enpol.2018.08.044
- en: Pandey, P., & Litoriya, R. (2020). Securing E-health Networks from Counterfeit
    Medicine Penetration Using Blockchain . Wireless Personal Communications . Advance
    online publication. doi:10.1007/s11277-020-07041-7
  id: totrans-426
  prefs: []
  type: TYPE_NORMAL
  zh: Pandey, P., & Litoriya, R. (2020). 使用区块链保护电子健康网络免受假药渗透的研究。《无线个人通信》。在线提前发表。doi:10.1007/s11277-020-07041-7
- en: 'Papert, M., Rimpler, P., & Pflaum, A. (2016a). Enhancing supply chain visibility
    in a pharmaceutical supply chain: Solutions based on automatic identification
    technology . International Journal of Physical Distribution & Logistics Management
    , 46(9), 859–884\. doi:10.1108/IJPDLM-06-2016-0151'
  id: totrans-427
  prefs: []
  type: TYPE_NORMAL
  zh: Papert, M., Rimpler, P., & Pflaum, A. (2016a). 在制药供应链中增强供应链可见性：基于自动识别技术的解决方案。《国际物流管理期刊》，46(9),
    859–884。doi:10.1108/IJPDLM-06-2016-0151
- en: 'Patel, K. K., Patel, S. M., & Scholar, P. G. (2016). Internet of Things-IOT:
    Definition, Characteristics, Architecture, Enabling Technologies, Application
    &amp; Future Challenges . International Journal of Engineering Science and Computing
    , 6(5), 1–10.'
  id: totrans-428
  prefs: []
  type: TYPE_NORMAL
  zh: 'Patel, K. K., Patel, S. M., & Scholar, P. G. (2016). 物联网-IOT: 定义、特征、架构、技术支持、应用和未来挑战。《国际工程科学与计算》,
    6(5), 1–10。'
- en: Popay, J., Roberts, H., Sowden, A., Petticrew, M., Arai, L., Rodgers, M., ...
    Duffy, S. (2006). Guidance on the conduct of narrative synthesis in systematic
    reviews. A product from the ESRC methods programme version. Academic Press.
  id: totrans-429
  prefs: []
  type: TYPE_NORMAL
  zh: Popay, J., Roberts, H., Sowden, A., Petticrew, M., Arai, L., Rodgers, M., ...
    Duffy, S. (2006). 系统综述中叙事综合的指导。ESRC方法计划版本的产品。学术出版社。
- en: Premkumar, A., & C, S. (2020). Application of Blockchain and IoT towards . Die
    Pharmazeutische Industrie , 729–733.
  id: totrans-430
  prefs: []
  type: TYPE_NORMAL
  zh: Premkumar, A., & C, S. (2020). 利用区块链和物联网应用于。药品工业，729–733。
- en: Radanović, I., & Likić, R. (2018). Opportunities for Use of Blockchain Technology
    in Medicine. Applied Health Economics and Health Policy, 16(5), 583–590.
  id: totrans-431
  prefs: []
  type: TYPE_NORMAL
  zh: Radanović, I., & Likić, R. (2018). 医学中区块链技术的应用机会。应用健康经济学和健康政策，16(5)，583–590。
- en: Raj, R., Rai, N., & Agarwal, S. (2019). Anticounterfeiting in Pharmaceutical
    Supply Chain by establishing Proof of Ownership. IEEE Region 10 Annual International
    Conference, Proceedings/TENCON, 1572–1577\. 10.1109/TENCON.2019.8929271
  id: totrans-432
  prefs: []
  type: TYPE_NORMAL
  zh: Raj, R., Rai, N., & Agarwal, S. (2019). 通过建立所有权证明在制药供应链中进行防伪。IEEE区域10年度国际会议，会议录/TENCON，1572–1577\.
    10.1109/TENCON.2019.8929271
- en: Redman, R. (2019). Walmart joins FDA blockchain pilot for prescription drugs.
    Supermarket News, 1–3.
  id: totrans-433
  prefs: []
  type: TYPE_NORMAL
  zh: Redman, R. (2019). 沃尔玛加入FDA的处方药区块链试点。超市新闻，1–3。
- en: Rejeb, A., Keogh, J. G., & Treiblmaier, H. (2019). Leveraging the Internet of
    Things and blockchain technology in Supply Chain Management . Future Internet
    , 11(7), 10–11\. doi:10.3390/fi11070161
  id: totrans-434
  prefs: []
  type: TYPE_NORMAL
  zh: Rejeb, A., Keogh, J. G., & Treiblmaier, H. (2019). 利用物联网和区块链技术进行供应链管理。未来互联网，11(7)，10–11\.
    doi:10.3390/fi11070161
- en: Rotunno, G., Mannarelli, C., Guglielmelli, P., Pacilli, A., Pancrazzi, A., Pieri,
    L., Fanelli, T., Bosi, A., & Vannucchi, A. M. (2014). Impact of calreticulin mutations
    on clinical and hematological phenotype and outcome in essential thrombocythemia.
    Blood , 123(10), 1552–1555\. doi:10.1182/blood-2013-11-538983
  id: totrans-435
  prefs: []
  type: TYPE_NORMAL
  zh: Rotunno, G., Mannarelli, C., Guglielmelli, P., Pacilli, A., Pancrazzi, A., Pieri,
    L., Fanelli, T., Bosi, A., & Vannucchi, A. M. (2014). 钙网蛋白突变对原发性血小板增多症的临床和血液表型以及结果的影响。血液，123(10)，1552–1555\.
    doi:10.1182/blood-2013-11-538983
- en: Sahoo, M., Singhar, S. S., Nayak, B., & Mohanta, B. K. (2019). A Blockchain
    Based Framework Secured by ECDSA to Curb Drug Counterfeiting. 2019 10th International
    Conference on Computing, Communication and Networking Technologies, ICCCNT 2019.
    10.1109/ICCCNT45670.2019.8944772
  id: totrans-436
  prefs: []
  type: TYPE_NORMAL
  zh: Sahoo, M., Singhar, S. S., Nayak, B., & Mohanta, B. K. (2019). 一种基于ECDSA的区块链框架，用于遏制药品伪造。2019年第10届计算，通信和网络技术国际会议，ICCCNT
    2019。10.1109/ICCCNT45670.2019.8944772
- en: 'Saunders, M. N., Altinay, L., & Riordan, K. (2009). The management of post-merger
    cultural integration: Implications from the hotel industry. Service Industries
    Journal , 29(10), 1359–1375\. doi:10.1080/02642060903026213'
  id: totrans-437
  prefs: []
  type: TYPE_NORMAL
  zh: Saunders, M. N., Altinay, L., & Riordan, K. (2009). 后并购文化整合的管理：从酒店业的含义。服务行业杂志，29(10)，1359–1375\.
    doi:10.1080/02642060903026213
- en: 'Settanni, E., Harrington, T.S., & Srai, J.S. (2017). Pharmaceutical supply
    chain models: A synthesis from a systems view of operations research. Operations
    Research Perspectives, 4, 74–95.'
  id: totrans-438
  prefs: []
  type: TYPE_NORMAL
  zh: Settanni, E., Harrington, T.S., & Srai, J.S. (2017). 制药供应链模型：来自运营研究系统视角的综合。运营研究透视，4，74–95。
- en: 'Shanley, A. (2017). Real-Time Logistics: Internet of things, advanced analytics,
    and blockchain solutions such as smart contracts promise to give manufacturers
    more control over products and supply chains. Pharmaceutical Technology Europe
    , 29(10), 46–48.'
  id: totrans-439
  prefs: []
  type: TYPE_NORMAL
  zh: Shanley, A. (2017). 实时物流：物联网、高级分析和区块链解决方案，如智能合同承诺给制造商更多对产品和供应链的控制。欧洲制药技术，29(10)，46–48。
- en: Shanley, A. (2018). FDA Provides More Clarity on DSCSA. Pharmaceutical Technology
    Europe, 30(11), 36–37.
  id: totrans-440
  prefs: []
  type: TYPE_NORMAL
  zh: Shanley, A. (2018). FDA就DSCSA提供了更多的澄清。欧洲制药技术，30(11)，36–37。
- en: Shi, J., Yi, D., & Kuang, J. (2019). Pharmaceutical Supply Chain Management
    System with Integration of IoT and Blockchain Technology. Lecture Notes in Computer
    Science (including subseries Lecture Notes in Artificial Intelligence and Lecture
    Notes in Bioinformatics), 11911 LNCS, 97–108\. doi:10.1007/978-3-030-34083-4_10
  id: totrans-441
  prefs: []
  type: TYPE_NORMAL
  zh: Shi, J., Yi, D., & Kuang, J. (2019). 利用物联网和区块链技术集成的制药供应链管理系统。计算机科学讲座（包括子系列人工智能讲座和生物信息学讲座），11911
    LNCS，97–108\. doi:10.1007/978-3-030-34083-4_10
- en: 'Sinclair, D., Shahriar, H., & Zhang, C. (2019, January). Security requirement
    prototyping with hyperledger composer for drug supply chain: a blockchain application.
    In Proceedings of the 3rd International Conference on Cryptography, Security and
    Privacy (pp. 158-163). 10.1145/3309074.3309104'
  id: totrans-442
  prefs: []
  type: TYPE_NORMAL
  zh: Sinclair, D., Shahriar, H., & Zhang, C. (2019年，一月). **使用Hyperledger Composer进行药品供应链安全需求原型设计：区块链应用**.
    在《密码学、安全和隐私第三届国际会议论文集》中（pp. 158-163）。 10.1145/3309074.3309104
- en: Srivastava, S., Bhadauria, A., Dhaneshwar, S., & Gupta, S. (2019). Traceability
    and transparency in supply chain management system of pharmaceutical goods through
    block chain . International Journal of Scientific and Technology Research , 8(12),
    3201–3206.
  id: totrans-443
  prefs: []
  type: TYPE_NORMAL
  zh: Srivastava, S., Bhadauria, A., Dhaneshwar, S., & Gupta, S. (2019). **通过区块链实现制药产品供应链管理系统的可追溯性和透明度**.
    《科学与技术研究国际杂志》，8(12)，3201–3206。
- en: 'Sunny, J., Undralla, N., & Pillai, V. M. (2020). Supply chain transparency
    through blockchain-based traceability: An overview with demonstration . Computers
    & Industrial Engineering , 150, 106895\. doi:10.1016/j.cie.2020.106895'
  id: totrans-444
  prefs: []
  type: TYPE_NORMAL
  zh: Sunny, J., Undralla, N., & Pillai, V. M. (2020). **通过基于区块链的追溯实现供应链透明度：概述与演示**.
    《计算机与工业工程》，150，106895。 doi:10.1016/j.cie.2020.106895
- en: 'Sylim, P., Liu, F., Marcelo, A., & Fontelo, P. (2018a). Blockchain technology
    for detecting falsified and substandard drugs in distribution: Pharmaceutical
    supply chain intervention . Journal of Medical Internet Research , 20(9), 1–12.'
  id: totrans-445
  prefs: []
  type: TYPE_NORMAL
  zh: Sylim, P., Liu, F., Marcelo, A., & Fontelo, P. (2018a). **区块链技术用于检测分销中的伪劣药品：制药供应链干预**.
    《医学互联网研究杂志》，20(9)，1–12。
- en: 'Thaul, S. (2015). Pharmaceutical supply chain security. Securing the Pharmaceutical
    Supply Chain: Issues and Perspectives, 1–26.'
  id: totrans-446
  prefs: []
  type: TYPE_NORMAL
  zh: Thaul, S. (2015). **制药供应链安全**. 《保障药品供应链安全：问题与展望》，1–26。
- en: 'Ting, S. L., Kwok, S. K., Tsang, A. H. C., & Lee, W. B. (2010). Enhancing the
    information transmission for pharmaceutical supply chain based on Radio Frequency
    Identification (RFID) and internet of things. SCMIS 2010 - Proceedings of 2010
    8th International Conference on Supply Chain Management and Information Systems:
    Logistics Systems and Engineering.'
  id: totrans-447
  prefs: []
  type: TYPE_NORMAL
  zh: Ting, S. L., Kwok, S. K., Tsang, A. H. C., & Lee, W. B. (2010). **基于射频识别(RFID)和物联网的制药供应链信息传输的增强**.
    SCMIS 2010 - 2010年第8届供应链管理与信息系统国际会议论文集：物流系统与工程。
- en: Tranfield, D., Denyer, D., & Smart, P. (2003). Towards a Methodology for Developing
    Evidence-Informed Management Knowledge by Means of Systematic Review . British
    Journal of Management , 14(3), 207–222\. doi:10.1111/1467-8551.00375
  id: totrans-448
  prefs: []
  type: TYPE_NORMAL
  zh: Tranfield, D., Denyer, D., & Smart, P. (2003). **通过系统性回顾开发基于证据的管理知识方法论的构建**.
    《英国管理杂志》，14(3)，207–222。 doi:10.1111/1467-8551.00375
- en: 'Treiblmaier, H. (2019). Toward More Rigorous Blockchain Research: Recommendations
    for Writing Blockchain Case Studies . Frontiers in Blockchain , 2(May), 1–15\.
    doi:10.3389/fbloc.2019.00003'
  id: totrans-449
  prefs: []
  type: TYPE_NORMAL
  zh: Treiblmaier, H. (2019). **朝着更严谨的区块链研究：编写区块链案例研究的建议**. 《区块链前沿》，2(May)，1–15。 doi:10.3389/fbloc.2019.00003
- en: Tseng, J.-H., Liao, Y.-C., Chong, B., & Liao, S.-W. (2018). Governance on the
    drug supply chain via gcoin blockchain . International Journal of Environmental
    Research and Public Health , 15(6), 1055\. doi:10.3390/ijerph15061055
  id: totrans-450
  prefs: []
  type: TYPE_NORMAL
  zh: Tseng, J.-H., Liao, Y.-C., Chong, B., & Liao, S.-W. (2018). **通过gcoin区块链治理药品供应链**.
    《国际环境研究与公共卫生杂志》，15(6)，1055。 doi:10.3390/ijerph15061055
- en: 'Uddin, M., Salah, K., Jayaraman, R., Pesic, S., & Ellahham, S. (2021). Blockchain
    for drug traceability: Architectures and open challenges . Health Informatics
    Journal , 27(2). doi:10.1177/14604582211011228'
  id: totrans-451
  prefs: []
  type: TYPE_NORMAL
  zh: Uddin, M., Salah, K., Jayaraman, R., Pesic, S., & Ellahham, S. (2021). **药品追溯的区块链：架构和面临的挑战**.
    《健康信息学杂志》，27(2)。 doi:10.1177/14604582211011228
- en: Vecchione, A. (2017). Blockchain tech could track pharmacy supply chain . Drug
    Topics , 161(11).
  id: totrans-452
  prefs: []
  type: TYPE_NORMAL
  zh: Vecchione, A. (2017). **区块链技术可以追踪药品供应链**. 《药品主题》，161(11)。
- en: 'WHO. (2010). Monitoring the Building Blocks of Health Systems : a Handbook
    of Indicators and . WHO.'
  id: totrans-453
  prefs: []
  type: TYPE_NORMAL
  zh: WHO. (2010). **监测卫生系统基础结构的搭建：指标和手册**. 世界卫生组织。
- en: Wu, H., Li, Z., King, B., Miled, Z. B., Wassick, J., & Tazelaar, J. (2017).
    A distributed ledger for supply chain physical distribution visibility. Information,
    8(4). doi:10.3390/info8040137
  id: totrans-454
  prefs: []
  type: TYPE_NORMAL
  zh: Wu, H., Li, Z., King, B., Miled, Z. B., Wassick, J., & Tazelaar, J. (2017).
    **供应链物流可见性的分布式分类帐**. 《信息》，8(4)。 doi:10.3390/info8040137
- en: Xie, W., Wang, B., Ye, Z., Wu, W., You, J., & Zhou, Q. (2019). Simulation-based
    Blockchain Design to Secure Biopharmaceutical Supply Chain. Proceedings - Winter
    Simulation Conference, 797–808\. 10.1109/WSC40007.2019.9004696
  id: totrans-455
  prefs: []
  type: TYPE_NORMAL
  zh: Xie, W., Wang, B., Ye, Z., Wu, W., You, J., & Zhou, Q. (2019). **基于仿真的区块链设计以确保生物制药供应链的安全**。
    《冬季模拟会议论文集》，797–808。 10.1109/WSC40007.2019.9004696
- en: Yadav, A.S., Selva, N.S., & Tandon, A. (2020). Medicine manufacturing industries
    supply chain management for blockchain application using artificial neural networks.
    International Journal of Advanced Science and Technology, 29(8), 1294–1301.
  id: totrans-456
  prefs: []
  type: TYPE_NORMAL
  zh: Yadav, A.S., Selva, N.S., & Tandon, A. (2020). 利用人工神经网络的区块链应用于药品制造业供应链管理。国际高级科学与技术杂志,
    29(8), 1294–1301.
- en: Yong, B., Shen, J., Liu, X., Li, F., Chen, H., & Zhou, Q. (2020). An intelligent
    blockchain-based system for safe vaccine supply and supervision . International
    Journal of Information Management , 52, 52\. doi:10.1016/j.ijinfomgt.2019.10.009
  id: totrans-457
  prefs: []
  type: TYPE_NORMAL
  zh: 勇, B., 沈健, 刘鑫, 李飞, 陈辉, & 周琦. (2020). 一种基于智能区块链的安全疫苗供应与监管系统 . 信息管理国际期刊 , 52,
    52\. doi:10.1016/j.ijinfomgt.2019.10.009
- en: ZhouW.PiramuthuS. (2014, June). Security/privacy of wearable fitness tracking
    IoT devices. In 2014 9th Iberian Conference on Information Systems and Technologies
    (CISTI) (pp. 1-5). IEEE. 10.1109/CISTI.2014.6877073
  id: totrans-458
  prefs: []
  type: TYPE_NORMAL
  zh: 周文平, PiramuthuS. (2014年6月). 可穿戴健身追踪物联网设备的安全/隐私。在2014年第9届伊比利亚信息系统和技术会议(CISTI)中
    (pp. 1-5). IEEE. 10.1109/CISTI.2014.6877073
- en: Zhou, Y., Cahya, S., Combs, S. A., Nicolaou, C. A., Wang, J., Desai, P. V.,
    & Shen, J. (2019). Exploring Tunable Hyperparameters for Deep Neural Networks
    with Industrial ADME Data Sets . Journal of Chemical Information and Modeling
    , 59(3), 1005–1016\. doi:10.1021/acs.jcim.8b00671
  id: totrans-459
  prefs: []
  type: TYPE_NORMAL
  zh: 周勇, Cahya, S., Combs, S. A., Nicolaou, C. A., 王杰, Desai, P. V., & 沈健. (2019).
    使用工业ADME数据集探索深度神经网络的可调参数. 化学信息与建模杂志 , 59(3), 1005–1016\. doi:10.1021/acs.jcim.8b00671
